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“Here is a community where obesity signifies success. High risk foods are linked to 
enjoyment of life. Weight loss is stigmatized.  To convince an obese person who feels 
like he/she is „having the best of life‟ to change his/her lifestyle is an enormous 
challenge, especially if asked: „What constitutes health?‟” 
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ABSTRACT 
 
Background: Between 2010 and 2030, a 69% increase in type-2 diabetes is expected 
in low-income countries compared to a 20% increase in high income countries. Yet 
health system responsiveness to non-communicable diseases has been slow in sub-
Saharan Africa. Data on the prevalence of type 2 diabetes and its associated factors in 
mainly rural settings is lacking, yet such data can guide planning for diabetes control. 
Objective: The aim of these studies was to assess the prevalence of type 2 diabetes, 
its risk factors, risk perceptions, and possible screening tools among people aged 35-
60 years so as to inform primary care level intervention in rural low-income settings.  
Methods: Four studies (I-IV) were conducted among people aged 35-60 years in a 
mainly rural demographic surveillance site in eastern Uganda (2011-2013). Study I, a 
cross-sectional survey assessed the prevalence of diabetes-related risk factors 
(including overweight, hypertension and seven socio-behavioural risk factors) in 
1,656 people. Study II then estimated the prevalence of abnormal glucose regulation 
(AGR) using fasting plasma glucose (FPG), and assessed its socio-behavioural 
correlates in 1,497 people. To compare the utility of FPG and glycated haemoglobin 
(HbA1C) rapid tests in risk stratification, a comparative survey of 795 people was 
nested into study II (Study III). To assess perceptions about diabetes, 12 Focus Group 
Discussions were conducted among people afflicted or at higher risk of type 2 
diabetes (Study IV). The assessments used standard measurements and cut-offs. 
Results: About 18% of people aged 35-60 years were overweight, while 21% had 
hypertension. Women (OR 3.7; 95% CI 2.7-5.1), peri-urban dwellers (OR 2.5; 95% 
CI 1.5-3.0), and wealthier people (OR 4.1; 95% CI 2.4-7.0) were more likely to be 
overweight. Only 34% had adequate knowledge about lifestyle diseases (I). 
Prevalence of diabetes was 7.4% while pre-diabetes was 8.6% and 20.2% with WHO 
and American Diabetes Association criteria respectively (II). Prevalence of AGR was 
twice higher in obese people compared to those with a normal BMI (APRR 1.9, 95% 
CI 1.3-2.8) (II). Sufficient physical activity and diverse diet were associated with 
lower likelihood of AGR (II). The direct medical cost of screening one person was 
US$0.53, translating to US$2 per person detected with AGR. Agreement between 
FPG (the reference) and HbA1C in classifying diabetes was moderate (Kappa=22.9; 
AUC =75%), while that for AGR was low (Kappa=11.0; AUC=59%) (III). However, 
agreement was high (over 90%) among negative tests and in participants with risk 
factors for type 2 diabetes. FPG was more practical than HbA1C (III).  Participants‟ 
strong perceptions of diabetes as a very severe disease were incongruent with their 
perceived urgency for lifestyle change (IV).While people with diabetes perceive 
obesity as „sickness‟, those without diabetes say it signifies „success‟ (IV). Poverty, 
access to food and large families were cited as barriers to healthy diets. Domestic 
work was the preferred platform for physical activity increments. 
Conclusions: Obesity, insufficient physical activity and unhealthy diets are possible 
aids to identifying people at higher risk of type 2 diabetes in primary care. Mass 
screening for abnormal glucose regulation may not be affordable to struggling health 
systems. However, rapid tests have utility in further evaluation of people with risk 
factors. Health education about lifestyle diseases is a priority and should target to 
change the community‟s notion of health and healthy lifestyles. Several challenges of 
adding NCD services to overstretched health systems come to light. 
 
Key words: Type 2 diabetes, pre-diabetes, hypertension, abnormal glucose 
regulation, NCD prevention, low income setting, lifestyle, screening, primary care 
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OPERATIONAL DEFINITIONS 
 
Abnormal glucose regulation: An abnormality in the body‟s metabolism of glucose, 
manifested as above-average levels of blood sugar or its associated parameters. It is a 
continuum that includes diabetes and pre-diabetes states (WHO and IDF 2006) 
 
Health system: That complex whole that includes the organisation of people, 
institutions and resources to deliver health care services to meet the health needs of 
target populations (WHO 2007) 
 
Higher risk person for type 2 diabetes: In this thesis, defined as a person with one or 
more risk factors for type 2 diabetes 
 
Lifestyle: It is the typical way of life of an individual, group or community. It is 
shaped by individual choices and external (societal and environmental) influences 
(Stuckler and Siegel 2011) 
 
Modifiable risk factors: Risk factors for a disease that can be altered by making 
appropriate interventions of a pharmacologic, behavioural, psychosocial or 
environmental nature (Lagerros and Rossner 2013) 
 
Most-at-risk person for type 2 diabetes: In this thesis, defined as a person with 
abnormal glucose regulation. Abnormal glucose regulation has been shown to represent 
the highest risk status for development of type 2 diabetes (Chen et al. 2003) 
 
Non communicable disease: A disease condition that is not directly transmitted from 
one person to another (WHO 2011c) 
 
Prevention: Actions taken before the occurrence of a disease in an individual or a 
community to minimize the possibility of its occurrence. It includes primary 
prevention (at the community level) and secondary prevention (at the health facilities) 
  
Risk stratification: The process of categorizing people on the basis of their level of 
risk for a particular health condition, using physical, biological or psychosocial 
parameters (Mendis et al. 2007) 
 
Screening: A strategy for identifying people with unrecognized disease or high risk 
states. It can be based on laboratory tests or by checking for symptoms closely 
associated with the disease. Screening is „targeted‟ when it is selectively done for a 
particular category of people (Gordis 2008) 
 
Self-monitoring of health: Refers to actions taken to monitor one‟s own health. 
They may include periodic checks on physical, physiological and psychosocial 
parameters as well as the adherence to drugs and lifestyle adjustments  
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PREFACE 
 
That mid-morning telephone call was no ordinary one. Maternal instinct told her, well 
before the caller‟s pronouncement, that the situation was irredeemably hopeless. She 
did not hide any emotion when she cried out, arms stretched in a resigned stance: „My 
son is dead! Parents are not supposed to bury their children - it should be the other 
way round‟. Shortly after saying that, she, a known hypertensive, fainted.  
 
The young man in question had only been outwardly ill for less than four weeks. 
Even then, the illness did not appear that serious to the handful of people he had 
confided in. Only recently had he complained of feeling „weak‟. He had continued to 
report for work every day despite feeling unwell – urgent deadlines had to be met. 
The only health workers he had consulted when in control of his life were at a local 
private clinic. He was first treated for malaria. It was during one of the consultations 
that he had challenged the health workers, using his lay knowledge of medicine: „why 
don‟t you check my urine sugar?‟ They discovered he had ketones in his urine. A 
diagnosis of type 2 diabetes ensued, and he was started on two classes of oral 
medications to control his blood sugar. (Three weeks later…) Following a set of 
distress calls that fateful morning, his second line of confidants had come to the same 
conclusion – that he had to be rushed to the referral hospital. He had fainted and 
slipped into a comma while explaining something on the phone! The hospital team 
was fast, but his blood pressure could not hold up and his sighing breaths worsened. 
He passed away, quietly, after approximately three hours of rigorous resuscitation. 
The autopsy raised eyebrows – he had suffered a massive but silent myocardial 
infarction (a heart attack), exacerbated by his metabolic condition.  
 
As a witness to this hullaballoo, several questions popped up in my mind. How could 
such a thing have happened to a person only in his third decade of life? He had just 
bought a new car, baptised his daughter (one of two little children), and was roofing 
his new house. For an illness that often progresses slowly, how could it have evaded 
the radar to this tragic point? Truth be told, some premonitions came months ago. He 
had gained an awful load of weight and, according to confidants, even had a 
hypertension scare.  What should it have taken for him to act in time to disarm the 
hands of death? The lurking answer to each question was the need for action.  
 
Millions of people are trapped in a lifestyle of risk. A seductive environment plays on 
the psyche to curtail healthy choices. The semblance of enjoyment that a world of 
sedentariness, obesity, carbohydrate cravings and fried food brings has compromised 
human resilience in a species known to survive by adapting. Trim college graduates 
change rapidly after studies. A white-collar job and a car mean they sit more. 
Disposable income attracts previously inaccessible amenities. Subliminal dietary 
indulgence takes over. The same vagaries have permeated the rural folk, entrapping 
them too in a culture of pervasive repose. Traditional foods rich in fibre and minerals 
are disappearing from the dinner table, replaced by cheap refined foods. The villager, 
known to be a work-horse, has increasingly retreated to a passive keeper. For one 
third of the last decade, I have tried to study type 2 diabetes. However, the avoidable 
death of that man catalysed my resolve to act. This thesis, my humble contribution to 
a thirsty knowledge space, highlights some options for strengthening diabetes care 
and prevention in a low income setting. For while death is inevitable, lifestyle related 
deaths among thirty-something-year-olds are highly preventable.  
 1 
 
1 BACKGROUND 
 
1.1 RISING BURDEN OF NCDs IN LOW INCOME COUNTRIES 
Non-communicable diseases (NCDs) have become a leading global health challenge.  
Taken together, NCDs represent the single largest cause of mortality in adults 
worldwide. Of an estimated 57 million deaths that occurred globally in 2008, 36 
million (i.e. 63%) were due to NCDs (WHO 2011c). The leading causes of NCD-
attributable mortality are cardiovascular diseases (CVDs), cancers, chronic 
respiratory diseases and type 2 diabetes. As the populations of more countries age, 
these numbers will rise. Although the NCD burden is highest in the higher income 
countries (HICs) (WHO 2011b, WHO 2011c), emerging evidence shows that future 
rise in NCDs will be disproportionately higher in low- and middle-income countries 
(LMICs) compared to the HICs. Already, nearly 80% of deaths due to cardio-vascular 
diseases occur in low- and middle-income countries (Cooper et al. 1998, Seedat 
2007). Estimates from 23 high burden low- and middle-income countries show that 
NCDs were responsible for 64% of all deaths (Alwan et al. 2010).  
 
Because mortality is a natural consequence of aging, premature mortality is a better 
indicator of the impact of NCDs on a population than crude mortality. In low- and 
middle-income countries, NCDs are increasingly occurring in younger working age 
people compared to the higher income countries (Unwin and Alberti 2006), affecting 
the economic wellbeing of their dependants. About 30% of NCD related deaths in 
LMICs occur in people aged less than 60 years, compared to 13% in the HICs (WHO 
2011c). In 2008, NCD attributed age-standardised death rates were estimated to be 
65% higher in low-income compared to higher income countries (WHO 2011c). 
NCDs are the leading causes of death in all regions of the world except for Africa. 
However, while NCD deaths are projected to increase by 15% globally between 2010 
and 2020 the greatest increases will be in Africa and South-East Asia, where they will 
increase by over 20%. In contrast, there will be no significant rise in NCDs in Europe 
(WHO 2011c). NCDs are projected to cause almost three-quarters as many deaths as 
communicable, maternal, perinatal, and nutritional diseases combined by 2020, and to 
exceed them by 2030 (WHO 2011c). Indeed in some sub-Saharan Africa countries 
such as Mauritius and Seychelles, NCDs are already the leading cause of mortality, 
responsible for 40% of all deaths (Bovet et al. 2007).  
 
The increase in NCDs is attributed to interrelated changes in population-level 
demographic, social and economic factors influenced by globalization (de-Graft 
Aikins et al. 2010, Maher et al. 2010). This state is often referred to as the 
„Epidemiological Transition‟ (Omran 1971).  Propelling the upsurge of NCDs is the 
growing prevalence of their associated risk factors, especially hypertension, smoking, 
harmful alcohol taking, insufficient physical activity and obesity/raised cholesterol. 
Obesity is fuelled by increasingly sedentary lifestyles short on physical exertion and 
high on risky foods (sugar, saturated fats, and refined carbohydrates) (Addo et al. 
2007, Hossain et al. 2007) in a growing culture of chronic over-nutrition. In LMICs 
such risk factors are concentrated in a burgeoning middle class in the urban areas. 
However, available evidence though patchy, shows that these risk factors are 
increasing in the rural areas due to rapid adoption of „western‟ lifestyles and 
increasing access to unhealthy food.  
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Proven cost-effective strategies are available for reducing chronic disease risk, 
including both population-wide and individual risk approaches (Lim et al. 2007, 
Mendis et al. 2007, Simmons et al. 2010). Several studies have demonstrated that 
behavioural interventions substantially lower the risk of diabetes in people with 
Impaired Glucose Tolerance (IGT) (Pan et al. 1997 , Knowler et al. 2002). The 
Finnish Diabetes Prevention Study (FDPS)  (Lindstrom et al. 2003) and its replica 
studies using the „FINDRISK‟ tool in the Americas and Asia  consistently show that 
intensive interventions targeted to high risk persons can sustainably reduce incidence 
of type 2 diabetes. Other evidence shows that community level pragmatic 
interventions too can substantially reduce cardio-vascular risk factors.  Learning from 
the controlled trials, Finland initiated a massive country wide prevention program for 
NCDs, and there is evidence of pay-offs in reducing some risk factors at the national 
level (Rautio et al. 2014). The Västerbotten and Norsjo community studies in Sweden 
and the Otsego-Schohaire county study in New York state also provide examples 
(Weinehall et al. 2001a, Weinehall et al. 2001b). However, while evidence of 
efficacious interventions has been widely demonstrated in high income countries, 
very little of such evidence has been generated from sub-Saharan Africa (Bischoff et 
al. 2009). Results of one of the few such pilots in Cameroon indicate that appropriate 
NCD programmes can be achieved in sub-Saharan Africa by optimizing human 
resources and the health system (Bischoff et al. 2009).  
 
The NCD agenda is gaining momentum globally. In May 2004, the 57
th
 World Health 
Assembly adopted a major resolution on NCDs that calls upon WHO member states 
to develop strategies to address this growing problem. The same assembly adopted 
the WHO Strategy on Diet and Physical Activity. On May 13, 2010, the United 
Nations General Assembly (UNGASS) passed resolution 265 on „Prevention and 
control of non-communicable diseases‟, a major political statement calling on Heads-
of-State to address NCDs. In September 2011, the UN General Assembly convened a 
„High Level‟ plenary meeting for Heads-of-State on NCDs. Out of this meeting, and 
its associated „outcome document‟, is expected to come a series of programmatic 
steps by all UN members to address this growing global challenge  (Alleyne et al. 
2010). However, progress may not be as fast as the urgency for action merits.  
 
Rising burden amid data scarcity: The rising burden of NCDs in low income 
countries is not matched by availability of context specific data, yet such data are 
crucial for planning and monitoring. NCD surveillance systems in most LICs are 
weak (WHO 2011c). Available data is patchy, very localized, and variable both in 
quality and methods. NCD data are often not sufficiently integrated into national 
health information systems (WHO 2011c) while health facility records are grossly 
incomplete due to under-diagnosis.  
 
Due to the glaring gaps in routine data, epidemiologic studies provide the bulk of the 
current evidence for understanding NCDs in sub-Saharan Africa. Three key 
publications provide a synopsis of the burden of NCDs in Africa: 1) The article 
„NCDs in SSA: What we know now‟ (Dalal et al. 2011) is a systematic review of 
epidemiological studies in the region. It shows that prevalence of NCDs varies 
considerably between countries, urban-rural gradients and some sub-populations. 
However, community based epidemiological studies are few and among these, South 
Africa and urban areas are over-represented. By 2010, only nine African countries 
had conducted national NCD surveys (Hall et al. 2011). 2) The WHO Global status 
report on NCDs (WHO 2011c), and 3) the WHO Atlas of African Health Statistics 
 3 
 
2011 (WHO-AFRO 2011), present estimates from epidemiological studies and show 
that SSA has a substantial burden of NCDs.  
 
However the modelling of NCD burden for sub-Saharan Africa in these global reports 
is based on critically few studies some with inadequate sample sizes, low 
representation of rural areas and infrequent repetitiveness (Hall et al. 2011). Key 
projections for Africa are therefore likely to be inaccurate because some assumptions 
carried from studies in HICs do not hold for sub-Saharan Africa - for example, while 
estimates in these global status reports show that obesity in HICs is higher in men, 
findings from most population-based studies in sub-Saharan Africa are contrary. 
 
1.2 TYPE 2 DIABETES 
Diabetes Mellitus is a health-threatening NCD with increasing prevalence worldwide. 
It is characterized by chronic hyperglycaemia, leading to micro-vascular 
complications affecting the kidneys, eyes and peripheral nerves and macro-vascular 
complications affecting blood vessels and the heart. According to Shaw et al, the 
world prevalence of diabetes among adults was estimated at 6.4% in 2010. Current 
projections by the International Diabetes Federation‟s (IDF) 6th Edition of the World 
Diabetes Atlas show that there were 382 million people with diabetes in 2013 and the 
number is expected to rise to 599 million (or 8% prevalence) by 2035 (IDF 2013).  
 
Table 1: Trends in world-wide prevalence of diabetes and projected prevalence by 2035 
2000 177 Million Global Burden of Disease Study WHO 
2003 194 Million IDF Atlas 2
nd
 Edition 
2010 285 Million Shaw et al 2010 
2030 522 Million IDF Atlas 5
th
 Edition 
2035 592 Million IDF Atlas 6
th
 Edition 
 
The prevalence of type-2 diabetes is rising in sub-Saharan Africa too (Mbanya et al. 
2010, Maher and Sekajugo 2011). According to the World Diabetes Foundation, there 
were an estimated 7.1 million cases of diabetes in Africa in 2003. Diabetes accounted 
for an estimated 6% of deaths in Africa in 2010 (Roglic and Unwin 2010). Between 
2010 and 2030, a 69% increase in type-2 diabetes is expected in low-income 
countries compared to a 20% increase in high income countries (Shaw et al. 2010). 
This increase will result in substantial strain on health systems already facing a high 
burden of communicable diseases (Abegunde et al. 2007, Mbanya et al. 2010).  
 
Some types of diabetes arise at younger ages in Africa, with socio-economic 
consequences to affected families. The rate of undiagnosed diabetes in sub-Saharan 
Africa is high (Mbanya et al. 2010). Individuals who are unaware that they have 
diabetes are at very high risk of chronic irreversible complications. A summary of the 
prevalence of type 2 diabetes in sub-Saharan Africa is provided in three recent 
publications: 1) Diabetes in SSA 1999-2011 (Hall et al. 2011), which is a systematic 
review; 2) New insights on diabetes mellitus and obesity in Africa part 1 (Kengne et 
al. 2013a), also a systematic review, and 3) the IDF Atlas 6
th
 Edition (IDF 2013).  
 
According to Hall et al, type 2 diabetes accounts for over 90% of diabetes cases in 
SSA. Diabetes prevalence varies between countries and rural-urban gradients, from 
0.6% in rural Uganda to 12% in urban Kenya (Hall et al. 2011). Reported type 1 
diabetes prevalence is low (from 4 per 100,000 in Mozambique to 12 per 100,000 in 
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Zambia). Gestational diabetes ranged from 0% in Tanzania to 9% in Ethiopia. 40% of 
people with diabetes were not aware of their condition (Hall et al. 2011).  
 
There is insufficient data on the prevalence of diabetes in rural settings in SSA. 
Available surveys are patchy, with many countries and rural contexts under-
represented (Kengne et al. 2013a).  Most of the available studies took a whole 
population view (Mbanya and Ramiaya 2006, Mbanya et al. 2010, Oladapo et al. 
2010, Dalal et al. 2011, Hall et al. 2011, Maher et al. 2011), few focusing on higher 
risk age-groups. Population-wide studies tend to return very low levels of prevalence 
especially in the rural areas because they include younger participants at much lower 
risk. More prevalence studies that target most-at-risk sub-groups are needed (like 
people older than 30 years) to generate evidence for targeted interventions. 
 
Type 2 diabetes in Uganda: Uganda has a predominantly agrarian economy with 
increasing urbanization and a rapidly growing population. While communicable 
diseases and acute maternal/perinatal conditions comprise about 70% of the burden of 
disease (MOH 2010a), the burden of NCDs is increasing too. The most common 
NCDs in Uganda are: diabetes, hypertension and cardiovascular diseases, and some 
cancers. In the 1960s, diabetes was rare in Ugandan. However, three decades later the 
National Referral Hospital registered over 5,000 new patients in a five year period in 
the 1990s, according to un-published reports from the Ministry of Health (Sensasi 
2006). Similar trends have been registered in up-country hospitals. In Mbale regional 
referral hospital (Eastern Uganda) diabetes cases increased from 80 patients per year 
in 1994 to over 600 per year in 2004, from the same unpublished reports. A 10-fold 
increase in type 2 diabetes is projected between 2005 and 2025 (Sensasi 2006). The 
highest occurrence is recorded in the Central Region (Sensasi 2006), probably due to 
higher socio-economic status, urbanisation, and adoption of western life-styles.  
 
An unpublished report by the Ministry of Health entitled „A rapid assessment of 
morbidity and mortality due to NCDs in Uganda‟ shows that diabetes accounts for 
25% of NCD related deaths among people hospitalized due to NCDs. This report 
estimated that there were 74,354 newly diagnosed diabetes cases in health facilities in 
the financial year 2009/10 compared to 58,523 in 2005/06 representing a 27% 
increase over five years. Maher and colleagues estimate that there are about 98,000 
diagnosed people with diabetes in Uganda, with an expected increase to 328,000 by 
2030 (Maher et al. 2010). These estimates are way below those of the Uganda 
Diabetes Association which indicates that about 4% of Ugandans (or 1,120,000 
people) suffer from type 2 diabetes. Uganda‟s public health system is therefore only 
handling a fraction of the burden of diabetes in the country. The rest are likely to die 
un-detected in the community, or to seek remedies from alternative practitioners.  
 
There have been very few population-based studies on the prevalence of type 2 
diabetes in Uganda. A cross-sectional study in Kampala and Mukono Districts in 
2002 estimated the prevalence of type 2 diabetes to be 8% among people aged ≥35 
years  (Lasky et al. 2002). However, these districts have a mainly semi-urban 
population. Another survey in rural southern Uganda estimated the prevalence of 
diabetes at 0.6% (Maher et al. 2011). That survey however did not provide age-
specific prevalence rates yet it included a wide age range (≥13 years). 
 
As a key knowledge gap, estimates of the burden of diabetes in Uganda are patchy. 
More surveys with a rural and higher risk focus are needed to estimate the number of 
most-at-risk persons that need care. Without specific evidence from prevalence data, 
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it is difficult to justify where to target scarce resources (Lindstrom and Tuomilehto 
2003, Ambady and Chamukuttan 2008).  
 
1.3 RISK FACTORS FOR TYPE 2 DIABETES 
Decades of research have shown that much of the burden of chronic diseases is 
attributable to multiple lifestyle factors working collectively. Proximate risk factors 
for type 2 diabetes are obesity, family history, insufficient physical activity, raised 
cholesterol, tobacco use, harmful use of alcohol, unhealthy diets and hypertension. 
Studies have also shown a link between NCDs and stress (Eriksson et al. 2008, 
Eriksson et al. 2013). Lindenberg, Ostergren and colleagues have cited a close 
association between psychosocial stress and exhaustion with disease (Lindeberg et al. 
2011). Because all these factors are modifiable, NCDs are to an extent preventable  
(Miranda et al. 2008). Personal lifestyle measures to reduce risk of type 2 diabetes 
have been known for decades (Stuckler and Siegel 2011, Lagerros and Rossner 2013, 
Schellenberg et al. 2013). They include: Healthy diets, physical activity and regular 
monitoring of health parameters (body weight, blood sugar, blood pressure, blood 
lipids, and adherence to therapy) (Pan et al. 1997 , Booth et al. 2013 ). Others are 
cessation of smoking and harmful alcohol intake (Stuckler and Siegel 2011).   
 
While sedentariness is highest in HICs, high levels are now increasingly seen in some 
LMICs (WHO 2011c). Smoking is still low in many LICs but data from 23 high 
burden LMICs shows that it is increasing (Alwan et al. 2010). Adult per capita 
consumption of alcohol is highest in HICs, but nearly as high in some LMICs, 
especially of local potent brew (WHO 2011c). Dangerous alcohol consumption has 
also been linked to other lifestyle diseases (Choudhry et al. 2014). Unhealthy diets are 
rising in lower-resource settings. In some countries in sub-Saharan Africa (e.g. 
Ghana, South Africa and Cameroon), hypertension has increased to epidemic 
proportions (Fezeu et al. 2006, Thorogood et al. 2007, Bosu 2010). Overweight has 
tripled in sub-Saharan Africa over the last two decades (Hossain et al. 2007).  
 
A synopsis of the distribution of risk factors for type 2 diabetes in sub-Saharan Africa 
is presented in three systematic reviews: (Addo et al. 2007, Dalal et al. 2011, Kengne 
et al. 2013a). According to these reviews, prevalence of risk factors varies 
considerably between countries, urban-rural gradients and gender. Obesity rates 
ranged from 0.4 to 43%; smoking from 0.4% to 71%. Hypertension is the most 
frequently reported cardiovascular risk factor in Africa, with prevalence ranging from 
4% to 65% across contexts (Dalal et al. 2011, Kengne et al. 2013a). Hypertension is 
consistently equal in men and women, higher in urban areas, and increases with age  
(Dalal et al. 2011). Less than 40% of people with hypertension have been detected 
and of those detected, less than 30% are on treatment. For those on treatment, less 
than 20% are controlled (Dalal et al. 2011). 
 
Most evidence on cross-linkages between risk factors for type 2 diabetes is from high 
income countries (Mendis et al. 2004) and may not apply to other contexts (Miranda 
et al. 2008). For example, contrary to what is observed in Europe, obesity in Africa is 
predominant among women compared to men, but smoking is higher in men (Dalal et 
al. 2011). More than half of the LMICs are in the early stage of the nutritional 
transition (Abrahams et al. 2011). The distribution of overweight in such countries is 
still socially segregated, wealthier persons being more likely to be obese (Fezeu et al. 
2006, Subramanian et al. 2009). Some data however show that in transitioning 
countries, obesity is increasingly occurring in low socio-economic status groups 
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(Hossain et al. 2007). Some transitioning countries face the paradox of families in 
which the children are underweight and the adults are overweight (Hossain et al. 
2007). 
 
The „degenerative‟ models of NCD causation pay little attention to processes that 
build up to the optimal phenotypic state leading to disease (Miranda et al. 2008). 
Known „proximate‟ risk factors are in reality underlied or modified by other context 
specific factors, yet few studies explore these relationships. Effective prevention 
requires unravelling these root causes of risk (Miranda et al. 2008). These underlying 
causes are often deeply rooted in a society and, in complex causal pathways, act 
across an individual‟s life course, driven by societal norms (Penn et al. 2013), to 
create the optimal phenotypic state for type 2 diabetes („developmental hypotheses‟)   
(Miranda et al. 2008). Quoting the book „Sick Societies‟, „societies in which people 
are born, live, and age create the individual‟s risks for chronic diseases, for which 
individuals have little choice‟(Stuckler and Siegel 2011). 
 
Studies on the distribution of type 2 diabetes related risk factors in sub-Saharan 
Africa are patchy, with many contexts especially the rural areas insufficiently 
explored (Dalal et al. 2011). Even fewer studies have assessed the cross linkages 
between risk factors (WHO 2011c)  yet latent factors are important in contextualizing 
interventions. Three population-based studies on the prevalence of CVD risk factors 
in Uganda and another in Cameroon focused on demographic correlates of either 
hypertension or abnormal glucose regulation (Lasky et al. 2002, Fezeu et al. 2006, 
Wamala et al. 2009, Maher et al. 2011) but did not include behavioural correlates. 
The lack of a holistic assessment of socio-behavioural risk factors is noticeable in 
other studies in sub-Saharan Africa (Addo et al. 2007, Mbanya et al. 2010, Dalal et al. 
2011, Hall et al. 2011).  
 
Likewise, very few studies have explored community perceptions about risk and 
preventive behaviours. Therefore, while the recommended behaviours are well 
known, there is inadequate information on forms of these behaviours that are feasible 
within the normative contexts of communities in sub-Saharan Africa (Whyte 2012). 
Lifestyle measures ought to be relevant to the context in which they are applied 
(Carmoi et al. 2008). 
 
1.4 EARLY DETECTION, DIAGNOSIS AND MANAGEMENT OF 
DIABETES 
Individual targeted interventions for prevention of type 2 diabetes require risk 
stratification and/or diagnosis (Beaglehole et al. 2008). People with type 2 diabetes 
often undergo a long pre-disease period during which they are exposed to detectable 
risk factors (Lindstrom et al. 2003, Ambady and Chamukuttan 2008). Many of these 
risk factors can be assessed in primary care, providing an opportunity for risk 
stratification. Concurrently, measurable metabolic changes occur, often referred to as 
„the metabolic syndrome‟. Pre-diabetes, the penultimate stage in these processes 
represents the „most-at-risk‟ category for type 2 diabetes (Chen et al. 2003, Meigs et 
al. 2003, Edelman et al. 2004, Coronado-Malagon et al. 2009). Identifying individuals 
with pre-diabetes enables preventive measures to be invoked earlier (Anand et al. 
2003, Waugh et al. 2007, WHO 2010b, Yoon et al. 2013). However, very few 
patients are detected early in LICs (Ambady and Chamukuttan 2008), losing an 
opportunity for prevention.  Given the limited use of the Oral Glucose Tolerance Test 
(OGTT) in African surveys, the extent of undiagnosed diabetes and pre-diabetes is 
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less clear, but is probably high, in some contexts as high as 90% (Kengne et al. 
2013b).  
 
Risk stratification using biological markers requires valid, easy to use, affordable and 
acceptable tests usable at primary care facilities. Type 2 diabetes and pre-diabetes are 
detected either through an Oral Glucose Tolerance Test, Fasting Plasma Glucose 
(FPG) or Glycated Haemoglobin (HbA1C). Diagnostic cut-offs for these tests have 
been defined by the WHO and the American Diabetes Association (ADA) (WHO and 
IDF 2006, ADA 2013). Pre-diabetes is defined by three criteria: Impaired Glucose 
Tolerance (determined by the OGTT), Impaired Fasting Glucose (determined by 
FPG) and HbA1C levels between 5.7- 6.4%. However, due to resource constraints and 
late presentation, many health facilities in sub-Saharan Africa rely on random blood 
sugar (RBS) for diagnosis of diabetes. The debate about which tests are suitable for 
primary care screening in LICs continues. While the OGTT is the more sensitive test 
(Lyon et al. 2004), it has a lengthy cumbersome procedure, poor reproducibility, and 
questionable cost-effectiveness (Lyon et al. 2004, Wilson et al. 2009, Herman and 
Fajans 2010). FPG is easier, cheaper and more reproducible, but has lower sensitivity 
and high pre-analytical variability (Kumar et al. 2010).  
 
In 2009, experts from the ADA, the European Association for the Study of Diabetes, 
and the International Diabetes Federation recommended that HbA1C should be the 
primary test for early detection of type 2 diabetes and pre-diabetes in asymptomatic 
persons (ADA 2013). In 2011, WHO too recommended that HbA1C is useful for 
diabetes screening, conditional to „stringent quality assurance and 
standardization‟(WHO 2011e). HbA1C does not require fasting, and it is stable over 
2–3 months (Jimeno Mollet et al. 2004, Kumar et al. 2010). However, it is costly 
(Herman and Fajans 2010) and it is affected by hemoglobinopathies, triglycerides, 
and common drugs like Aspirin (Kumar et al. 2010, Unnikrishnan and Mohan 2013). 
Evidence of its value in detection of pre-diabetes is also inconclusive (WHO 2011e). 
 
Both the FPG and HbA1C are now also available as point-of-care tests. However, their 
utility as PHC level screening tools for diabetes and abnormal glucose regulation is 
not yet clear, as is their feasibility for use by primary care workers.  
 
Utility of risk scores: Because of the obvious financial constraints that PHC systems 
face in LICs, many countries cannot afford mass opportunistic screening for bio-
markers. A worthy alternative to biomarker-based opportunistic screening is the use 
of risk scores (Beaglehole et al. 2008). Lindstrom and Tuomilehto demonstrated the 
utility of these „risk engines‟ as simple, inexpensive, non-invasive and reliable tools 
to identify most-at-risk persons (Lindstrom and Tuomilehto 2003). Their model 
included age, body mass index (BMI), waist circumference, hypertension, physical 
activity, blood glucose, smoking, alcohol taking and diet as proximate predictors of 
diabetes risk. However, these factors include blood glucose measurement, which may 
not be affordable in low income settings. Another model called TAG-IT (Tool to 
Assess likelihood
 
of fasting Glucose ImpairmenT) (Koopman et al. 2008) showed that 
age, sex, BMI, family
 
history of diabetes, resting heart rate, and elevated blood 
pressure predict 74% of diabetes risk and BMI alone predicted up to 64% of risk.  
 
Combinations of risk factors may therefore provide optimum prediction of risk for 
diabetes and could be the starting point for interventions. However, studies on such 
„risk engines‟ have been mainly conducted in high income countries. Risk models 
relevant for Africa are lacking (Kengne et al. 2013a). 
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Care after diagnosis: Several studies from HICs (ACCORD, UKPDS, ADVANCE 
and VADT trials) show that treat-to-target interventions among diabetes patients can 
substantially slow the progression of micro-vascular damage, and therefore reduce the 
severe major complications like kidney disease, diabetic foot and retinopathy 
(Macisaac and Jerums 2011). However, evidence on overrall reduction of CVD 
related mortality remains equivocal, with some large trials like ACCORD showing 
that intensive interventions impact on CVD risk while others like the UKPDS show 
that they are not efficacious in this dimension  (Macisaac and Jerums 2011). Intense 
interventions have also been associated with higher incidence of hypoglycaemia 
(Macisaac and Jerums 2011). 
 
The substantial advances in treatment and care for type 2 diabetes seen in HICs are 
out of reach for many countries in sub-Saharan Africa where care for diabetes 
remains suboptimal (Kengne et al. 2013a). Because of this, there are low levels of 
glucose control among diagnosed cases (Hall et al. 2011). The majority of patients 
have irreversible complications at diagnosis, which impacts on treatment success, 
quality of life and cost of treatment. In the systematic review by Hall et al, the 
proportions of patients with diabetes related complications in different countries in 
sub-Saharan Africa ranged from 7-63% for retinopathy, 27-66% for neuropathy, and 
10-83% for micro-albuminuria (Hall et al. 2011). Because patients present late, most 
of them require insulin as first line treatment. Novel and more stable insulins and 
drugs are not affordable for many countries. Five-year mortality of patients ranged 
from 4 to 57% (Hall et al. 2011). Access to HbA1C monitoring for diagnosed cases is 
low. The Diabcare Africa study found that only 47% of patients in leading diabetes 
centres had at least one HbA1C measurement over 12 months, ranging from 28% in 
Eastern Africa to 81% in some Central African countries (Kengne et al. 2013a). 
 
According to the chronic care model (Bodenheimer et al. 2002), management of 
diabetes is increasingly a dynamic partnership between the patient and the service 
provider, the former having substantial autonomy in self-care. However, patients in 
Africa lack the amenities to take charge of their care (Kengne et al. 2013a). One study 
from Nigeria showed that only 27% of patients had access to home-based glucose 
monitoring devices (Kengne et al. 2013a). Attainment of lifestyle targets is sub-
optimal in many settings while hypoglycaemia from treatment poses a higher threat 
than hyperglycaemia (Kengne et al. 2013a). Low access to refrigerators in rural areas 
means too that insulin is stored inappropriately. Patients have to travel frequently to 
health facilities for insulin refills because they cannot take longer term doses. 
 
1.5 BEHAVIOUR CHANGE EDUCATION ON DIABETES IN LICs 
Among proposed „best-buys‟ at the population-level (priority actions to scale up the 
NCD response by countries), the WHO cites mass health education as a requisite 
strategy (WHO 2011c). The diffusion of health information on diabetes and NCDs in 
sub-Saharan Africa is low because in many settings the focus is on acute infectious 
diseases (Remais et al. 2013). Behaviour change theory indicates that awareness per-
se may not necessarily change human behaviour but rather, adoption of health 
behaviours is a sequential process with different stages (Glanz et al. 2008). However 
several systematic reviews failed to demonstrate that the efficacy of interventions 
using the trans-theoretical model is dependent on the sequenced way in which 
lifestyle interventions are introduced (Tuah et al. 2011, Mastellos et al. 2014).  
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At the individual level, planned behaviour is influenced by subjective norms and the 
environment (Ajzen 2011). The success of lifestyle interventions depends on realistic 
goal setting and relevant options (Health Quality Ontario 2009 , Bray et al. 2013), yet 
current approaches to health education are often provider centred (Angermayr et al. 
2010, Gilstrap et al. 2013, Schellenberg et al. 2013). Because individuals are 
influenced by societal norms (Penn et al. 2013), lifestyle education ought to be 
relevant to the normative context in which it is applied (Carmoi et al. 2008). While 
the recommended lifestyles behaviours are well known, there is inadequate 
information on forms of these behaviours that are feasible within the normative 
contexts of communities in sub-Saharan Africa (Whyte 2012). Studies are necessary 
to explore models for roll out of lifestyle interventions in Africa. 
 
1.6 ECONOMIC BURDEN OF TYPE 2 DIABETES IN LICs 
It has been argued that primary prevention (by fighting major risk factors like tobacco 
use, alcohol abuse, risky diets and low physical activity) is more cost-effective than 
improving secondary care in fighting the NCD epidemic (Probst-Hensch et al. 2011). 
For 23 selected LMICs which account for 80% of the total burden of NCDs, an 
estimated US$84 billion of economic production will be lost from heart disease, 
stroke, and diabetes between 2006 and 2015 if nothing is done. Achievement of a 
global goal for NCD control (i.e. a 2% yearly reduction in chronic disease death rates 
over the next 10 years) would avert 24 million deaths in these countries, saving an 
estimated US$8 billion (i.e. 10% of the projected loss) (Abegunde et al. 2007). 
According to Hall et al (Hall et al. 2011), the annual cost of diabetes in SSA is 
estimated at US$67 billion, or US$ 8,836 per patient. The health budgets of virtually 
all countries in the region cannot cope with such costs, yet many more patients 
remain undetected (Kengne et al. 2013b).  
 
Accumulating evidence shows type 2 diabetes is an impoverishing illness in low 
income countries (Kengne et al. 2013b).  The annualized direct medical costs of 
diabetes treatment across private and public clinics in Khartoum for example was 
estimated at US$175, equivalent to about 9% of the annual wage of a patient with 
diabetes in this setting (Elrayah-Eliadarous et al. 2010). This cost excludes indirect 
expenditures on transport and food. The cost to the patient for the treatment of severe 
diabetic foot ulcers is equivalent to about two years of average annual income in 
Tanzania, compared to one years‟ wages in the USA (Kengne et al. 2013b). Patients 
with NCDs in rural settings in India pay considerably more than patients with 
communicable diseases, often obliterating household income and forcing them to rely 
on informal intra-family cross-subsidisation (Binnendijk et al. 2012).  
 
Very little of the evidence on cost-effective prevention strategies has been generated 
from Africa (Jones and Geneau 2012). Modelling studies suggest that implementing 
the most effective interventions to control diabetes is likely more costly for African 
countries than other regions of the world (Kengne et al. 2013b). There is inadequate 
information on the economic benefit of population level interventions like health 
education compared to individual interventions like screening and intensified lifestyle 
programs.  In Uganda, no studies have been conducted to assess the direct and hidden 
costs of diabetes although anecdotal evidence shows that patients spend substantially 
on drugs (due to frequent stock outs), blood sugar testing, treatment of complications, 
transport to the few diabetes clinics and long waiting times.  
 
 10 
 
1.7 DIABETES AND NCDS IN STRUGGLING HEALTH SYSTEMS 
The increasing incidence of chronic diseases in countries in sub-Saharan Africa is a 
challenge to their health systems (Dalal et al. 2011). On one hand, acute conditions 
are still responsible for a larger share of the disease burden (WHO-AFRO 2011). Six 
conditions (maternal/peri-natal problems, malaria, acute respiratory infections, 
diarrhoeal diseases, HIV/AIDs and TB) account for about 54% of the burden of 
disease in Africa (WHO-AFRO 2011) and 60% of the disease burden in Uganda 
(MOH 2010a). Primary health care systems in this setting have for long been 
designed to address these conditions (Maher et al. 2010), yet they still face major 
challenges regarding access, quality, utilisation and efficiency of existing services 
(Rutebemberwa et al. 2009, Waiswa et al. 2010).  
 
Because NCDs now account for at least 20% of the disease burden in sub-Saharan 
Africa (Lopez et al. 2006) they can no longer be ignored or seen as a distraction from 
control of infectious diseases (Miranda et al. 2008). A „dual burden of disease‟ is 
imminent (Dalal et al. 2011) yet health systems in the region have not adjusted fast 
enough (Maher et al. 2010). Many countries in Africa do not have established 
prevention programs for NCDs (Kengne et al. 2013b) and where they exist, the 
programs are much smaller in scale compared to those targeting communicable 
diseases (Samb et al. 2010, Kengne et al. 2013b). Capacity for control of NCDs varies 
considerably across countries, but is mostly inadequate (Alwan et al. 2010, Kengne et 
al. 2013b). Integration of care for both communicable and non-communicable 
diseases is low, yet opportunities exist for such integration (Remais et al. 2013).  
 
A major shift towards enhancement of NCD control in the health systems of low 
income countries is therefore necessary (Beaglehole et al. 2008, Maher et al. 2010). 
However, because LICs already face many challenges, integration of NCD services 
requires significant strengthening of their health systems (Beaglehole et al. 2008).  
NCDs interventions should not be introduced as vertical programs (Remais et al. 
2013). The challenge is how to build health systems that can balance both acute and 
chronic conditions, with sufficient quality, access and outcomes without „crashing‟. 
The system for delivery of interventions for NCD prevention is almost as important 
as the interventions themselves (Beaglehole et al. 2008).   
 
In a context where PHC level strategies for NCDs are limited, examination of the 
health system building blocks (WHO 2007) highlights several challenges that need to 
be overcome. Applying this model, Samb et al determined that the factors that limit 
countries‟ capacity to implement proven strategies for chronic diseases relate to the 
way in which health systems are designed and function (Samb et al. 2010). A 
synopsis of some of the challenges is presented as follows: 
 
Human resources: Sub-Saharan Africa has the lowest ratio of health workers to 
service population (WHO-AFRO 2011) compared to other regions. Many critical 
services are provided by auxiliary health workers (Bischoff et al. 2009). Integration of 
NCD packages would mean more workload. Although nurses will need to play a 
leading role in NCD care (Awah et al. 2008, Beaglehole et al. 2008, Bischoff et al. 
2009), task shifting to auxiliary health workers will be inevitable. More evidence is 
needed on NCD service delivery tasks that can be shifted to other actors in the health 
system. 
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Services organisation and delivery: Service delivery packages in LICs were primarily 
oriented to communicable diseases (Maher et al. 2010, Remais et al. 2013) along with 
guidelines and job-aids. To meet the challenge of NCDs, primary health care services 
will have to be strengthened substantially (Strong et al. 2006) to reach communities, 
high risk individuals, and people with disease. Innovative packages of known 
efficacious strategies ought to be delivered to these three audiences with sufficient 
quality and cross-linkages (Beaglehole et al. 2008). Selection of appropriate 
pharmacologic, lifestyle and psychosocial measures based on efficacy, cost and 
feasibility is necessary (Beaglehole et al. 2008). Integration of NCD services may 
however disrupt other services substantially (Remais et al. 2013). Translational 
studies are needed on how NCD services can be layered into existing and innovative 
platforms with minimal disruption. „Community-led‟ service delivery models, piloted 
in countries like Bangladesh, should be explored in sub-Saharan Africa. More 
evidence is also needed in defining most-at-risk populations, and in tailoring different 
services to different levels of care. Strengthening public-private partnerships in NCD 
service delivery is necessary too, since the private sector is responsible for a large 
portion of health service delivery in Africa (Rutebemberwa et al. 2009).  
 
Diagnostics: There are calls to simplify the diagnosis of type 2 diabetes (Mostafa et 
al. 2010). The availability of effective point-of-care (POC) tests in primary care is 
increasingly necessary (Little 2005). With the low access to laboratories at primary 
care levels in sub-Saharan Africa, innovative approaches to risk assessment and 
stratification also need to be developed. Risk factor based algorithms that are 
amenable to use at primary care levels ought to be explored, especially those that can 
easily be implemented by nurses and community health workers.  
 
Medicines and therapeutics: In health systems that lack essential drugs at PHC levels, 
identification of more people with disease is likely to exacerbate existing shortages 
(Beaglehole et al. 2008). Questions on the ethics of screening without ability to treat 
arise. Significant preparation for the leap in demand for treatment must precede any 
efforts at screening. Essential drugs should be made accessible, and contextually 
relevant therapeutic regimens developed, both pharmaceutical and lifestyle based. 
 
Health Information: At the centre of the health system are the communities, high risk 
persons, and people with disease together with their families. Effective NCD services 
should be able to rally these audiences in mutually enhancing ways. Currently, the 
bulk of health education messages in sub-Saharan Africa is oriented towards acute 
conditions and infectious diseases (Maher et al. 2010). Culturally-relevant 
interventions require a clear understanding of the priority risk factors in the 
communities, how communities perceive risk in context, and their readiness to take 
up lifestyle adjustments. Such quantitative and qualitative data are lacking for many 
contexts in sub-Saharan Africa (Kengne et al. 2013b).  
 
Financing: Few countries in Africa have met the pledge to spend 15% of their 
national budgets on health as per the Abuja Declaration (WHO 2011a). NCD 
integration would no doubt exacerbate financing challenges. Transfer of costs to 
individuals and families would escalate the high out-of-pocket expenditures already 
incurred by households (WHO-AFRO 2011). Uganda‟s government for instance 
spends about US$6 per capita on health compared to US$24 in out-of-pocket 
expenditure per-capita (WHO 2009). Interventions deployable at minimal costs with 
acceptable access, equity and effectiveness need to be explored for sub-Saharan 
Africa. The private sector, which in many countries accounts for a substantial share of 
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health service delivery, could also play a key role in NCD financing (Ghatak et al. 
2008). More evidence is needed too on the cost-effectiveness of different service 
packages in Africa. 
 
Governance and policy: Raising the priority of NCDs is a political process (Geneau 
et al. 2010). Countries that are still in the early stages of the NCD transition are 
especially important because structural measures can avert an NCD epidemic 
(Abrahams et al. 2011). On a positive note, there are indications that chronic diseases 
and NCDs are increasingly receiving more attention in Africa (Kengne et al. 2013b). 
As of 2010, 89% of African countries had a dedicated unit or its equivalent within the 
national Ministry of Health responsible for NCDs and 61% had funding available for 
NCDs. However, only about 26% of the countries had an operational policy or  
programme for type 2 diabetes (Kengne et al. 2013b). Policy makers urgently need to 
develop policies on NCD prevention to support the service delivery environment 
(Lachat et al. 2013). There would be need for substantial leadership at all levels. 
Robinson and Hort propose a four step reform process: 1) building political 
commitment and addressing systems constraints, 2) developing public policies on 
prevention, 3) creating new service delivery models and, 4) ensuring equity in access 
(Robinson and Hort 2012).  
 
Learning from HIV care and communicable disease programs: There is a potential to 
learn from the successes in integration and scale up of HIV care in the development 
of a chronic care model for low income countries (Janssens et al. 2007), especially 
regarding quality of care, task shifting, intersectoral collaboration and enhancing 
adherence to therapy (Agnarson et al. 2010, Boruett et al. 2013). Important successes 
too have been registered in reduction of malaria, TB, and child mortality (UN Inter-
Agency Group 2013, WHO 2013). These programs have different funding streams, 
and were re-energized by major global policy and funding agenda. Lessons on how 
such global commitments were realised can be applied to the NCD agenda. 
 
NCDs and the Health System in Uganda: Uganda implements a level-based health 
care system for public health services (MOH 2010a): The „Health Centre II‟ (HCII) 
(at parish level) serves about 5000 people, is nurse-led and implements the „minimum 
activity package‟ (treating common diseases, antenatal care, immunisation, referral 
and outreaches) with no in-patient services. The „Health Centre III‟ (HC III) (at sub-
county level) is an intermediate facility serving about 25,000 people, with additional 
services including deliveries, limited in-patient care, maternity, TB treatment, and 
public health inspection services. It is headed by an auxiliary clinician cadre called a 
„Clinical Officer‟ and has a laboratory for basic tests (malaria, urinalysis, blood sugar, 
anaemia and tuberculosis). The „HCIV‟ and „district hospital‟ are referral units 
serving about 100,000 people in a zone called a Health Sub-district. They have 
medical officers and provide referral services. They are also responsible for providing 
technical support to lower facilities and to plan for service delivery in the zone. 
Alongside the public health services, the private sector plays a key role, accounting 
for over 40% of service delivery. It includes „not-for-profit‟ providers with service 
packages akin to those in the public health system often subsidised by government, 
and „for-profit‟ providers with mainly curative services. Alongside formal health care 
are community health workers (CHWs). Their responsibility is mobilizing 
communities for health programs, health education and peer support. 
 
Uganda has established an NCD Program Office in the Ministry of Health. NCDs 
have featured in the last three national health sector strategic plans (MOH 2010a). 
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Policies and regulations on tobacco and alcohol control have been implemented. The 
NCD coordinating office has rallied different stakeholders to form an „NCD forum‟ 
which meets regularly to harmonize strategies. A food and nutrition policy is also 
under development by the Ministry of Agriculture. The Uganda NCD Alliance, a not-
for-profit agency uses targeted advocacy and outreach to promote NCD action.  
 
However, akin to other LICs, Uganda‟s strategy for NCD prevention is evolving 
(MOH 2010a). At the time of this thesis, Uganda‟s only official guidelines for type 2 
diabetes were published in 1998 (Masaba et al. 1998). These guidelines focus on 
symptomatic persons in secondary care settings, and less on prevention. The Ministry 
of Health and partners are developing a set of new guidelines and job aids to enhance 
NCD service delivery in primary care. The current structure and delivery of services 
for type 2 diabetes and NCDs in Uganda has many gaps and opportunities. While the 
„Uganda National Minimum Health Care Package‟ (UNMHCP) mentions NCDs 
(MOH 2010a), preventive services at the different service delivery levels are patchy. 
A synopsis of the current service packages at different levels of care and how they 
relate to NCDs are presented in Table 2 below using type 2 diabetes as a tracer: 
 
Table 2: Current service delivery packages: Where are the NCD services in Uganda’s PHC 
facilities? 
Level Characteristics and current package NCD services (Type 2 diabetes as an 
example) 
Health facility based 
Health 
Centre I 
Village level (~500 people); Community 
Health workers (Home visiting,  peer 
education and mobilization of people to 
attend immunisation and other outreaches) 
Almost no involvement in diabetes 
related lifestyle education and patient 
support 
Health 
Centre II 
Parish level (~5000pple); Nurse-led; provide 
„Minimum Activity Package (Identify/treat 
common conditions (outpatient), prevention 
outreaches, referral of complicated cases) 
Predominantly malaria, acute respiratory 
infections, diarrhoea, immunisation and 
family planning; largely no services on 
diabetes prevention 
Health 
Centre 
III 
Sub-county level (~25,000pple); 
„Intermediate referral‟ package (Auxiliary 
clinical services; limited in-patient care, 
maternity/deliveries, lab for tuberculosis, 
malaria, urine, haemoglobin 
Can do blood and urine sugar tests but it 
is mostly for emergency obstetric care. 
Comprehensive HIV care provided in 
some of them but largely no diabetes 
prevention services. 
Health 
Centre 
IV/ 
Hospital 
At county/district level (~100,000pple); 
provides a „Comprehensive activity 
package‟: Clinician led, caesarean section, 
minor surgery, blood transfusion, planning 
and management support for the health 
service zone 
Provide diagnosis, treatment, follow-up 
of diabetes;  diagnosis is mainly based 
on classical symptoms and Random 
Blood Sugar; often have the only public 
diabetes clinic in the health service zone; 
largely no diabetes prevention services 
Private-
for-profit 
clinics 
Offer clinical services for common illnesses 
focusing on secondary care; they fill critical 
gaps in curative care 
Diagnosis, treatment, follow-up of 
diabetes 
Non-health facility based 
Private-
not-for 
profit 
They are major stakeholders in community 
based service delivery; they fill critical gaps 
in primary health care especially community 
mobilisation 
Limited involvement in NCD prevention 
Other 
Sectors 
outside 
health 
Other sector activities e.g. education, 
gender, labour and agriculture have minimal 
direct involvement 
Food policy under development; limited 
inter-sectoral actions targeting NCDs 
Folk Ill-structured; first and last resort; highly 
accessible 
Opportunistic services because of the 
gaps in existing formal services 
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Although there are many opportunities to integrate preventive services for type 2 
diabetes and NCDs into primary care in Uganda, a key knowledge gap exists 
regarding which service packages and specific actions can be integrated into existing 
PHC services at different levels without severely disrupting other services, and within 
the available resources. 
 
1.8 SUMMARY OF THE KEY KNOWLEDGE GAPS  
The rising burden of NCDs in low income countries is not matched by availability of 
context-specific epidemiological data regarding most-at-risk population sub-groups. 
Because surveillance systems for NCDs are weak, epidemiological studies are 
currently the main source of evidence yet available data are patchy, with inadequate 
representation of rural areas.  
 
Few studies have assessed the prevalence of diabetes and pre-diabetes in higher risk 
population categories and rural settings in sub-Saharan Africa. Most of the available 
studies take a whole population view and return very low levels of prevalence 
especially for rural areas. There is need for more studies to describe the epidemiology 
of type 2 diabetes in higher risk population groups like people older than 30 years.  
 
Few studies have characterized and quantified socio-behavioural risk factors for type 
2 diabetes in low income settings, and even fewer studies have explored the 
underlying drivers of the proximate risk factors in sub-Saharan Africa. Knowledge of 
such drivers would allow interventions to target the root causes of the proximate risk 
factors. 
 
There is limited data on the utility and cost implications of available screening tests 
that can aid in identification of the most-at-risk persons at primary care levels in sub-
Saharan Africa. There is also limited data on suitable socio-behavioural correlates of 
abnormal glucose regulation that can be used to develop risk scores to help in 
identification most-at-risk persons. These risk scores could provide an alternative to 
screening which is likely not affordable in most primary care contexts in LICs. Risk 
stratification allows scarce resources to be targeted to most-at-risk groups. 
 
Few studies have assessed the context specific perceptions of type 2 diabetes related 
risk factors, community perceptions regarding preventive behaviours and forms of 
these behaviours that are relevant and acceptable to target communities in rural 
Africa. This information is necessary to guide development of contextually relevant 
lifestyle interventions.  
 
Although there are many opportunities to integrate preventive services for type 2 
diabetes into primary care, a knowledge gap exists regarding which specific actions 
can be integrated at different levels of service delivery without severely disrupting 
service delivery, and within available resources. While a number of studies have 
demonstrated the effective strategies for type 2 diabetes prevention, very little of this 
evidence is coming from Africa. Basic information like direct costs of simple 
preventive procedures is lacking. More exploratory studies are needed to identify 
services that can be integrated into primary care and the implications to the health 
system of such integration. 
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2 PROBLEM STATEMENT AND RATIONALE 
 
2.1 STATEMENT OF THE PROBLEM 
This thesis focuses on four information gaps regarding the burden of type-2 diabetes 
and potential interventions for prevention and early detection of the disease in low-
income settings in sub-Saharan Africa. 
 
There is insufficient data on the prevalence of risk factors for type 2 diabetes in 
predominantly rural communities in sub-Saharan Africa. Existing data are patchy, 
with several countries and rural contexts under-represented. In addition, data on the 
socio-behavioural correlates that underlie key proximate risk factors like overweight 
and hypertension are lacking. These underlying drivers of risk are important for 
enriching behaviour change education messages and for identifying the priority target 
groups for health education (I).  
 
Data on the prevalence of type 2 diabetes and pre-diabetes in rural contexts in sub-
Saharan Africa are lacking. The few available studies with a rural outlook take a 
general population perspective and do not provide sufficient information on its 
distribution and correlates in higher risk population sub-groups like people older than 
30 years. Available studies therefore present a gap in clarifying which age-group 
should be prioritised for targeted interventions, the proportion of most-at-risk persons 
and the prevalence of undetected disease. Such information is necessary to justify 
preventive action at the individual and population level (II), but can also be 
triangulated with cost data to estimate the direct medical costs of screening for 
identification of most-at-risk persons (II).  
 
There is also insufficient information on suitable aids to identification of most-at-risk 
persons for type 2 diabetes in sub-Saharan Africa. Identifying individuals with 
abnormal glucose regulation enables intensified preventive measures to be invoked 
earlier. The utility of available rapid screening tests (FPG and HbA1C) in aiding risk 
stratification at primary care levels has not yet been adequately evaluated in Africa. 
(III). In addition, data on socio-behavioural correlates of abnormal glucose regulation 
which can aid risk stratification as an alternative to laboratory screening, are needed 
since screening is likely not affordable for many contexts in sub-Saharan Africa (II).  
 
Lastly, few studies have explored the communities‟ perceptions about recommended 
preventive lifestyles in Africa. Therefore, there is inadequate information on forms of 
these behaviours that are feasible, acceptable and relevant to the normative contexts 
of communities in sub-Saharan Africa. Without context specific options for lifestyle 
adjustment, behaviour change education messages targeting communities and 
individuals in rural sub-Saharan Africa may be irrelevant to their target audiences, 
especially regarding the normative environment affecting behaviour (IV).  
 
2.2 RATIONALE FOR THE STUDIES 
The majority of low income countries (including in sub-Saharan Africa) hardly have 
any large preventive programs for type-2 diabetes. As a result, most individuals with 
the disease present late, when life-style measures can no longer avert disease. There is 
insufficient information on how low income countries can approach the process of 
integration of prevention measures for type-2 diabetes in their essential health care 
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package. There is a need for evidence to back the selection of priority interventions at 
the community level, the health facility level and among higher risk persons.  
 
The relevance of population-level lifestyle interventions is in empowering 
communities with sufficient knowledge to be able to make informed choices. 
However, there is need for evidence on the most prevalent risk factors and their 
correlates, to guide development of such health education tools.   
 
Without prevalence data, it is difficult to plan for NCD prevention. Assessing 
prevalence in higher risk sub-groups (like people older than 30 years) clarifies 
whether the proportion of most-at-risk persons and people with disease necessitates 
urgent action, and whether it is justified to target services to specific sub-groups. The 
direct medical costs of detecting one most-at-risk person may also be determined, 
which in part illuminates the affordability of screening.   
 
In low income countries where prevalence of type 2 diabetes is still relatively low, 
risk stratification is necessary to identify the most-at-risk groups, so as to allow 
targeted intervention. However this requires the availability of simple, accessible, and 
cost effective diagnostic tests that can be deployed at point-of-care in primary care 
settings. There is need to explore the utility of available point-of-care tests in aiding 
risk stratification in low income countries. As an alternative to the screening tests, 
knowledge of the socio-behavioural correlates associated with type 2 diabetes 
provides background information on relevant variables to include in a risk score for 
behavioural risk assessment. Where laboratory diagnostics are lacking, such risk 
scores could be the plausible tool for risk assessment. 
 
Because individuals are influenced by societal norms, lifestyle measures ought to be 
relevant to the context in which they are applied. As an important part of the health 
system, health educators should be guided on the forms of recommended lifestyles 
that are relevant to the community norms in their specific cultural settings. This 
requires a context based assessment of how communities interpret the recommended 
measures for prevention of type 2 diabetes and how they can operationalize them.  
 
Figure 1 below summarises the key study questions for this thesis and how they relate 
to the community, people with undetected risk factors or disease, and people with 
detected risk factors or disease:  
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Figure 1: Conceptual framework: Type 2 diabetes - Prevalence, risk factors, 
perceptions and health system implications 
 
At the centre of NCDs/type 2 diabetes services in the health systems of low income 
countries are three target audiences: The general community, people with undetected 
risk factors and disease (together with their families) and people with detected risk 
factor or disease (together with their families). At the community level, it is necessary 
to know the magnitude of type 2 diabetes related risk factors, whether people are 
aware about lifestyle diseases and their perceptions on prevention. It is also necessary 
to establish whether the prevalence of type 2 diabetes is substantial in people aged 35-
60 years in the rural areas. For undetected risk and disease, knowledge of their 
magnitude clarifies the potential burden to the health system of their detection. The 
costs of screening can aid in computing the direct medical costs of such a screening 
program. It is also necessary to evaluate the utility of possible screening tests for use 
at primary care level. Knowing the socio-behavioural factors associated with AGR 
can inform the development of behavioural risk assessment tools. Among people with 
risk factors or disease, knowing their perceptions about prevention and the forms of 
lifestyle adjustments that are feasible to them can enhance lifestyle counselling by 
highlighting contextually relevant options. All this information can contribute to 
strengthening the health system responsiveness to type 2 diabetes prevention and 
care, in building an appropriate chronic care model for resource poor countries. 
 
THE 
COMMUNITY 
 
PEOPLE 
WITH UN-
DETECTED 
RISK 
FACTORS 
OR 
DISEASE 
 
PEOPLE WITH 
DETECTED RISK 
FACTORS OR 
DISEASE 
 
TYPE 2 DIABETES AND THE HEALTH SYSTEM 
Is the prevalence of risk factors substantial? 
Are people aware? What are their 
perceptions on prevention? 
Is the prevalence of abnormal glucose regulation 
(AGR) substantial in people aged 35-60? 
What forms of lifestyle change are 
contextually feasible/acceptable? 
 
Do rapid tests have utility for screening? 
What would be the direct medical cost of 
screening for AGR?  
Study 
I, IV 
III 
II 
IV 
Which other risk factors are closely 
associated with AGR? (II) 
 
II 
II 
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3 AIMS AND OBJECTIVES FOR THE STUDIES 
 
3.1 GENERAL AIM 
The aim of these studies was to assess the prevalence of type 2 diabetes, its risk 
factors, risk perceptions, and possible screening tools among people aged 35-60 years 
so as to inform primary care level prevention and management in rural low-income 
settings.  
 
3.2 SPECIFIC OBJECTIVES 
1. To determine the population level prevalence of type-2 diabetes related risk 
factors among people aged 35-60 years in a predominantly rural low income 
setting (Study I) 
2. To estimate the population level prevalence of abnormal glucose regulation and 
its associated factors among people aged 35-60 years in a predominantly rural 
setting (Study II) 
3. To compare the utility of two point-of-care tests in targeted screening to identify 
most-at-risk persons for type 2 diabetes in a predominantly rural low income 
setting (Study III) 
4. To identify perceptions about severity of type 2 diabetes and preventive lifestyles 
among people afflicted or at higher risk of type 2 diabetes in a low income setting 
(Study IV) 
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4 METHODS 
 
4.1 INTRODUCTION 
This thesis is a compilation of four studies each providing descriptive findings on an 
aspect pertinent to prevention of type 2 diabetes at primary care levels in a low 
income setting. Study I assesses the prevalence of risk factors for type 2 diabetes at 
the population level among people aged 35-60. Study II then examines the prevalence 
of type 2 diabetes and abnormal glucose regulation (diabetes and pre-diabetes) in the 
same population. Study III explores the utility of two possible tests in population 
level screening for abnormal glucose regulation, a high risk state for type 2 diabetes. 
Study IV then explores perceptions about preventive lifestyles among people afflicted 
or with risk factors for type 2 diabetes. 
 
4.2 STUDY SETTING AND STUDY POPULATION 
All studies were conducted in the Iganga-Mayuge Health and Demographic 
Surveillance Site (HDSS), located in two eastern Uganda districts of Iganga and 
Mayuge (Figure 2), approximately 120 kilometres from Kampala, the Capital of 
Uganda. Uganda is located in East Africa. Iganga and Mayuge are part of eight 
administrative districts of the Busoga region. 
 
In 2012, Iganga District had an estimated population of 466,200 (Uganda Bureau of 
Statistics 2007). The district has 101 health units, 83 of which (82%) are government 
owned. There is one general hospital (which provides referral services and hosts the 
only diabetes clinic in the district), three HC IV and 27 HC III. The rest are HC II. 
Mayuge District had an estimated population of 461,200 in 2012 (Uganda Bureau of 
Statistics 2007).  It has one private-not-for-profit hospital (patients pay some 
subsidised user fees), two HC IV (all government owned) and 35 HC II. Mayuge 
district contributed only 10% of the study participants due to the geographical spread 
of the HDSS. 
 
Approximately 90% of the population in both districts resides in the rural areas while 
7% are peri-urban. Small scale agriculture is the main economic activity, but petty 
trading is common in the semi-urban areas and fishing in the lake shore areas. The 
main language in the region is „Lusoga‟ a Bantu dialect.  
 
The HDSS is a geographical portion of these two districts, with a population of 
approximately 80,000 people in 65 villages. It has one town comprised of 13 villages 
(hereafter referred to as „peri-urban areas‟); the rest (80%) of the villages are rural. 
Apart from the routine demographic surveillance activities, add-on studies are often 
conducted within the HDSS, including this study. Data was collected in May-June 
2011 (I), March-April 2012 (II, III), and April-May 2013 (IV). The study population 
comprised adult men and women aged 35-60 years within the HDSS. All studies have 
focused on this particular age-group because of its higher likelihood for type 2 
diabetes related risk factors compared to the general population yet most existing 
population based studies do not provide specific data for this age-group. 
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Figure 2: Map of Uganda showing the study districts 
 
Health system provisions for diabetes care: Akin to other districts in Uganda, 
prevention programs for NCDs at primary care level are scanty. The system for 
diabetes care in Iganga and Mayuge districts is guided by Uganda‟s decentrallised 
public health care system (MOH 2010a), the Uganda‟s Clinical Guidelines (MOH 
2010b), and Guidelines for Non-communicable diseases at the district level (Masaba 
et al. 1998). These guidelines mostly focus on the person presenting with the classical 
symptoms of diabetes, by which stage the disease is advanced. Because of this, the 
management of type 2 diabetes in Uganda and Iganga-Mayuge is based at referral 
care facilities (HC IV and district hospitals), with lower health units expected to refer 
the suspected cases. Because services are based at referral facilities, patients often 
have to travel long distances to receive care. Not all referral facilities in the districts 
have the capacity to provide diabetes treatment and care. In Iganga district for 
instance, there is only one public facility that provides diabetes care, the district 
hospital.  
 
The diabetes clinic in Iganga Hospital runs once a week and currently has 354 
patients on follow-up, 201 of whom are women and and 153 are men. It is run by one 
Clinical Officer and two nurses. Over 60% of patients present with overt symptoms 
and need insulin. The clinic provides insulin, oral hypoglycaemics and lifestyle 
education to patients as the key therapies. Drugs are provided for free but with 
occasional stock-outs, requiring patients to buy them from private pharmacies in 
Iganga Municipality. Insulin costs approximately US$10 per week. Diabetes patients 
only get the opportunity to check their blood sugar at the clinic visit. At the start of 
these studies, there was only one glucometer, with patients paying approximately 2 
US$ per test as an out-of-pocket expenditure. The clinic does not provide health 
education on NCDs to people without diabetes, and neither does the district health 
team conduct such outreaches. Apart from the single diabetes care centre in the 
 21 
 
district, there are a few private-for-profit medical centres in the main town that offer 
medical treatment for type 2 diabetes. However, their services are often not affordable 
for the majority of patients. Yet unpublished data also shows that health workers in 
the two districts have low levels of awareness about diabetes prevention, early 
diagnosis and treatment.  
 
4.3 STUDY DESIGN AND SAMPLE SELECTION 
The overrall study design was a mixed methods approach. Study I and II employed a 
population-based cross-sectional study design. However, part of the data for study II 
was secondary data on socio-behavioural characteristics and physical measurements 
from study I while other data was collected by revisits to households. Study III was a 
cross-sectional comparative study, nested into Study II. Study III also included a 
qualitative component using key informants to compare feasibility of two screening 
tests. Study IV used a qualitative approach, employing Focus Group Discussions. 
 
Study I 
The sample size was based on the formula for cluster surveys [C=(Zα
2
PQ)D /δ2b] 
(Bennett et al. 1991, Kumar and Indrayan 2002): „Zα,‟ the standard normal deviate at 
95% confidence, is 1.96; „P‟, the prevalence of hypertension, the commonest 
proximate risk factor for Type 2 diabetes is 23% (Maher et al. 2011); „D‟, represents 
a „design effect‟ of 2; „δ‟, represents a sampling error of 3% and „b‟, the average 
number of individuals targeted per village was 40. Substituting, a minimum of 38 
clusters were needed for the survey, hence a minimum sample size of 1,680, from 42 
clusters, inclusive of a 10% adjustment for possible non-response.  
 
A multi-stage sampling strategy was used. The HDSS has a database of all 
households and household members by village together with their basic demographic 
characteristics like age and sex. This database is updated every six months. A sample 
of 42 villages (8 peri-urban and 34 rural) were selected, from which 1,680 target 
participants were sampled proportionate to the village population sizes, using simple 
random sampling. HDSS locator information was used to trace sampled participants 
to their households. 1,656 (98.6%) sampled individuals agreed to participate. 
 
Study II and III 
All individuals who participated in study I (1,656) were followed up for inclusion in 
study II of whom 1,497 agreed to participate (90.4%). Study III was nested into II. 
The sample size required for comparing differences in prevalence of AGR between 
FPG and HbA1C was determined using a formula for comparative studies (Fleiss et al. 
1980). At a significance level of 95%, power of 80%, estimated prevalence of AGR 
of 3% (Maher et al. 2011), and hypothesized difference in prevalence of AGR 
between the two tests at 3%, the minimum computed sample size was 792, adjusted 
to 879 to cater for 10% estimated non-response. A sub-sample of 879 of the 1,656 
participants in the larger study was therefore selected using simple random sampling, 
of who 795 actually participated (90.4%). A summary of the sample hierarchy for the 
three quantitative studies is presented in Figure 3 below: 
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Figure 3: Flow-chart showing the sample hierarchy for study I, II and III 
 
Study IV 
Focus group discussions were used, which allowed participants to describe their 
feelings and perceptions (Wiersma 1995). The FGDs were homogenous with respect 
to age, sex and type 2 diabetes status. A total of 12 FGDs of eight participants were 
held. This number of FGDs was selected to enable information saturation and 
comparison of perspectives from three main categories of participants: people with 
probable type 2 diabetes (referred to in the rest of the thesis as „people with 
diabetes‟), people with probable pre-diabetes (referred to as „people with pre-
diabetes‟) and obese people with normal fasting plasma glucose (referred to as 
„obese‟), stratified by gender and residence. The cut-offs for defining these glycaemic 
groups have been defined in the measurements section. We use the term to „probable‟ 
because the test used to classify diabetes (FPG) was non-confirmatory.  
 
The sampling was purposive, targeting three categories of discussants as highlighted. 
Participants were selected from those who participated in Study II. Using the study II 
database, three lists were generated by sorting individuals in the three categories. 
Each list was then stratified into males/females and into rural/peri-urban (to create 12 
categories). Eight participants were then selected from each sub-category to make 12 
FGDs. HDSS locator information was used to trace the sampled participants to their 
households. Consenting participants were invited to attend their respective FGD 
meeting. 
 
4.4 MEASUREMENTS 
Study I 
Research assistants collected data in two tiers: 1) A questionnaire to assess socio-
behavioural characteristics, and 2) physical measurements. 
 
Socio-behavioural variables: A structured questionnaire was used to collect data on 
socio-behavioural factors including demographic characteristics, socio-economic 
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status, family history of diabetes, psychosocial stress, physical activity, tobacco and 
alcohol use, knowledge about lifestyle-diseases and food frequency. The 
questionnaire was adapted from different tools that have been validated elsewhere.  
Most questions were adapted from the WHO Stepwise Approach to NCD 
Surveillance (STEPS) tool (WHO 2011d), which has been used for risk factor 
surveillance in some countries in Africa (Guthold et al. 2011). The STEPs tool 
derives items from other validated tools including the Global Physical Activity 
Questionnaire (Bull et al. 2009, Papathanasiou et al. 2009, Oyeyemi et al. 2011), 
questions on alcohol use and smoking (Ustun et al. 1998, Newcombe et al. 2005), 
questions on psychosocial stress (Eriksson et al. 2008) and the dietary diversity score 
(Ruel 2003, Savy et al. 2005). Post evaluation of the questions on knowledge about 
diabetes showed that they had excellent internal consistency (Cronbach‟s 
Alpha=82%). The questionnaire was translated into the local language and pre-tested. 
 
Socio-economic status (SES) was assessed using ownership of 11 household assets 
(UBOS and Macro 2007), following which principal components analysis (PCA) was 
done. The component on which most assets loaded provided an SES score for each 
participant. SES scores were then grouped into SES tertiles (UBOS and Macro 2007). 
 
Questions on physical activity assessed participants‟ undertaking of „vigorous-
intensity activities‟ and „moderate-intensity activities‟ and the time spent on each of 
these activities in a typical week. Participants were classified into those that met the 
WHO recommendations of at least 75 minutes of vigorous-intensity, or 150 minutes 
of moderate-intensity activities per week and those that did not (WHO 2010a).  
 
Tobacco use was assessed using questions on current or ever use of tobacco, whereas 
alcohol use was assessed with questions on frequency, type and quantity of alcohol 
consumed. Participants were classified as engaging in „harmful alcohol use‟ if they 
consumed the equivalent of at least 60 grams of pure alcohol either regularly or in a 
binge in the one month preceding the survey  (WHO 2000, WHO 2011f). Information 
was also collected on family history of diabetes, defined as a history of diabetes in 
one 1
st
 degree or at least two 2
nd
 degree relatives (Hilding et al. 2006). 
 
Psychosocial stress was measured in five domains (anxiety, apathy, depression, 
fatigue and insomnia) using five questions adapted from Sweden (Eriksson et al. 
2008). The maximum score on this scale was 20. Based on their total score, 
participants were classified into three stress levels by dividing the range of the scale 
into three equal parts (0-6=low, 7-13=Moderate, and 14-20=High stress).  
 
Knowledge about lifestyle diseases was measured in five domains using diabetes as a 
proxy: 1) Awareness about diabetes, 2) its symptoms, 3) its risk factors, 4) its 
prevention and 5) misconceptions. Participants were scored with a “1” for each item 
they knew, and with a “0” for those they did not know. The total score for 39 items in 
the assessment was used to grade participants into two knowledge levels: Inadequate 
(0-19) and Adequate (20-39) based on the mid-point of the score. 
 
Food frequency was assessed using recall of foods eaten in the previous seven days. 
Local foods were grouped into nine food groups recommended for dietary diversity 
assessments (Swindale and Punam 2005). Individual dietary diversity was then 
assessed by scoring “1” to a food group if the participant had eaten at least one food 
in that group, or a “0” if they had not (Swindale and Punam 2005). The maximum 
 24 
 
possible score was nine. A score of 0-3 was regarded as „low diversity‟, 4-6 as 
„moderate diversity‟ and 7-9 as „high diversity‟ (Swindale and Punam 2005). 
 
Physical measurements: Height was measured using standard height meters, with the 
participant standing upright. Weight was measured using calibrated Seca® scales, 
with the participant lightly clothed. BMI was calculated. A participant was classified 
as overweight if their BMI was 25 Kgm
-2
 or greater and obese if their BMI was 30 or 
greater (WHO 1995). Waist and hip circumference were measured using a tape 
measure. Waist circumference was measured around a horizontal plane through the 
mid-point between the lower costal margin and the iliac crest, waistline unclothed. 
Hip circumference was measured around a horizontal plane through the trochanters.  
To classify abdominal obesity, a normal waist circumference was ≤94 centimetres 
(cm) for males and ≤80 cm for females, a moderately elevated waist circumference 
was 94.1-102cm for males and 80.1-88cm for females, and a substantially elevated 
waist circumference was >102 cm for males and >88cm for females (WHO 1995).   
 
Two blood pressure (BP) measurements were taken (at least 5 minutes apart), with 
the participant seated, using a calibrated electronic BP device (Welch-Allyn®). The 
average was calculated to represent their BP. A participant was classified as having 
hypertension if their average systolic BP was 140mmHg or higher, or if their average 
diastolic BP was 90mmHg or higher, or if they were on anti-hypertensive treatment 
(Whitworth 2003). Pre-hypertension was defined as having an average systolic BP 
between 120 - 139mmHg, or an average diastolic BP between 80 - 89mmHg. 
 
Study II and III 
For each participant, Study II and III adopted the same physical and socio-
behavioural characteristics that were assessed in Study I. To this was added data on 
fasting plasma glucose (FPG) (for II and III) and haemoglobin A1C (for III only). 
Each participant was contacted on the day prior to their scheduled date for data 
collection and an appointment was sought for the following day. To obtain an FPG, 
they were requested not to eat anything on the appointment day until their blood test 
had been conducted. All appointments were set in the morning hours before 10.30am.  
Participants who had eaten anything on the appointment day were rescheduled.  
 
For each consenting participant a drop of blood was obtained from a finger prick 
using an automated lancing device and analysed for FPG using a glucometer (On-Call 
Plus ®, ACON). For the sub-sample of participants in study III, a second drop of 
blood was analysed for HbA1C using the A1cNow® (Bayer) Rapid Immuno-Assay.  
Both tests were in form of rapid kits. Point-of-care tests are widely recommended for 
monitoring of blood glucose and some brands have comparable validity to laboratory-
based tests (Little 2005, Shibata K et al. 2005, Lenters-Westra and Slingerland 2010, 
Wood et al. 2012). Because of their simple procedure, the tests were performed by 
nurses. From the product‟s information insert, the Coefficients of Variation (CV) for 
the On-Call ® Plus test are within acceptable range (less than 10%) for the different 
plasma glucose values in the range tested. For HbA1C, the new version of A1CNow+ 
is noted to have better performance through recent introduction of improved 
manufacturing, improved chemistry and improved calibration (Bode et al. 2007). 
 
Classification of AGR was based on the standard cut-offs for FPG and HbA1C as 
defined by the ADA (ADA 2013):  For FPG, 1) FPG <5.6 mmol/l was classified as 
normal; 2) FPG >6.9mmol/l was classified as diabetes; 3) FPG between 5.6-6.9 
mmol/l was classified as „pre-diabetes‟.  All participants with an FPG ≥5.6mmol/l 
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were classified as having „AGR‟. For HbA1C, 1) HbA1C <5.7% (or <39mmol/mol) 
was classified as having normal glycosylation; 2) HbA1C ≥6.5% (or ≥48mmol/mol) 
was classified diabetes; 3) HbA1C between 5.7% - 6.4% (39-46mmol/mol) was 
classified as „pre-diabetes‟. For HbA1C, „AGR‟ was defined as HbA1C ≥ 5.7% (or 
≥39mmol/mol). „AGR‟ therefore included both diabetes and pre-diabetes. 
 
Because the WHO has different cut-offs for FPG, a separate cross-analysis between 
FPG and HbA1C was also conducted using the WHO criteria (III). The WHO cut offs 
for FPG are (WHO and IDF 2006): 1) FPG <6.1mmol/l (normal); 2) FPG >6.9mmol/l 
(diabetes); 3) FPG between 6.1 - 6.9mmol/l (pre-diabetes). All participants with an 
FPG ≥6.1mmol/l were classified as having „AGR‟. 
 
Because the screening tests used in these assessments were all non-confirmatory, all 
classifications indicated are „probable‟.  
 
Direct medical cost of screening: Study II also estimated the cost of screening all 
people aged 35-60 years. Using a health services perspective, the direct medical costs 
of implementing such a program were computed and annualised for one round of 
health facility-based screening.  The main assumption is that all people aged 35-60 
years in the district (i.e. 13.5% of an estimated population of 466,200 (Uganda 
Bureau of Statistics 2007) are offered an FPG test once over a two year period at any 
visit to a public health facility with laboratory services. The two year period spreads 
out the costs from salaries and health worker time, which are not included in this 
analysis. The capital costs include: 1) The price of hand-held Glucometers (one each 
for 12 health facilities that offer laboratory services in Iganga district, assuming each 
Glucometer lasts three years); 2) The cost of training health workers (two each for 12 
health centres, and assuming that re-training occurs after five years). The recurrent 
costs include: 1) Costs of the FPG test strips (assuming a wastage rate of 2% as found 
in this study), and 2) the costs of batteries to power the Glucometers.  
 
Feasibility of FPG and HbA1C rapid tests: Study III assessed feasibility of using the 
FPG and HbA1C tests in screening. The study nurses were interviewed as key 
informants, to explore their experiences in using the two tests. Variables included: 
Ease of use, the test procedure, mistakes, and device error readings and their causes. 
This information was triangulated with trainers‟ observations regarding the duration 
of practice sessions required for research assistants to master the respective test 
procedures during their training, as well as observational data on the actual duration 
of each test as recorded during data collection.  
 
Study IV 
Two FGDs were held each day. Two moderators asked participants a series of open-
ended and probing questions using a prepared FGD Guide. The note-taker audio-
recorded the discussions while also taking notes and capturing the expressions. The 
discussions were held in the Local Council halls at six selected sub-county offices. 
 
To facilitate informed discussion on lifestyles (diet, physical activity and self-
monitoring), the moderators used an approach in which participants were told about 
the biomedical recommendations regarding a particular behaviour and were then 
asked 'whether they were feasible and how‟. This approach is similar to „motivational 
interviewing‟ proposed by Miller and Rollnick, where ambivalent issues are clarified 
so that the focus is on „eliciting motivators for change‟(Miller and Rollnick 2002).  
 
 26 
 
The FGD guide covered perceptions on five issues: 1) Severity of type 2 diabetes, 2) 
obesity, 3) healthy diet, 4) physical activity, and 5) self-monitoring of health. These 
issues were based on a review of articles on recommended lifestyles for prevention on 
type 2 diabetes (Lagerros and Rossner 2013, Schellenberg et al. 2013).  The FGD 
guide was reviewed by a multi-disciplinary team. It was translated to the local 
language (Lusoga) and back-translated to English for accuracy.  
 
Methodological approaches to promote validity included follow-up questions and 
probes, checking repeatedly to ascertain assertions and meanings, and using multiple 
coders in development of the codebook.  
 
4.5 DATA COLLECTION TEAMS 
Study I, II and III 
Data were collected by eleven teams, each comprising of two research assistants (a 
nurse and a social worker). The research assistants underwent three days of rigorous 
training (Study I) and three additional days of training to implement study II and III. 
 
Study IV 
The FGDs were moderated by the principal investigator a (male public health 
specialist) assisted by an experienced qualitative researcher (also a male). The use of 
two moderators was to allow sufficient probing. They were supported by a female 
interpreter and a female note-taker, both conversant with the local language, the 
former being a nurse and the latter a social scientist.   
 
4.6 DATA MANAGEMENT AND ANALYSIS 
Quantitative data (Studies I, II and III) 
Data were double entered in EpiData, cleaned and exported to STATA10 for analysis. 
Study I 
The prevalence of overweight and hypertension was calculated. Logistic regression 
was used to identify the socio-behavioural factors associated with being overweight 
and being hypertensive, at a significance level of p<0.05. Because waist 
circumference showed wide disparity between sexes, BMI was used for testing 
associations. Crude odds ratios (COR), adjusted odds ratios (AOR), and their 
respective 95% confidence intervals (CI) and p-values are reported. Model fit was 
evaluated using the Hosmer-Lemeshow test (Hosmer and Lemeshow 2000). 
 
Study II 
The prevalence of diabetes and pre-diabetes was calculated. To determine association 
between AGR and socio-behavioural factors, prevalence rate ratios (PRR) were used 
rather than odds ratios because the dependent variable (AGR) was highly prevalent. 
Odds Ratios tend to over-estimate the strength of association in such scenarios 
(Thompson et al. 1998, Lee et al. 2009). PRRs were estimated using the Modified 
Poisson regression analysis model, with robust standard errors (Thompson et al. 
1998). Unadjusted and adjusted PRRs, plus their confidence intervals (CI) and p-
values at =0.05 are presented.  
 
To estimate the cost of detecting one person with AGR, the estimated capital costs of 
such a program, scaled to the district level, were annualized and added to the 
estimated recurrent costs for one year to obtain the total annual cost. The cost per 
person screened was computed. The number of people with AGR that would be 
detected in one round of a health facility based district-wide screening program 
 27 
 
targeting people aged 35-60 years was computed based on the prevalence of AGR in 
this age-group. Thereafter, the cost of detecting one person with AGR was computed. 
Using prevalence data for overweight, we also assessed the cost of detecting one 
person with AGR if screening is targeted only to overweight persons. 
 
Study III 
The percentage agreement between the FPG and HBA1C tests in classifying diabetes 
and AGR was determined at the standard cut-offs and evaluated using the Kappa 
Statistic. We explored further the predictive value of HbA1C for FPG-defined diabetes 
status and FPG-defined AGR. The reason for using FPG as the reference was that the 
data seems to indicate that HbA1C was the less specific test. Percentage agreement 
was also compared for the two tests among sub-groups with risk factors for type 2 
diabetes. Receiver Operating Characteristic (ROC) curves were used to evaluate the 
performance of HBA1C in predicting FPG-defined diabetes status and AGR.  
 
Qualitative analysis (Study IV) 
FGD recordings were transcribed and translated into English by an experienced 
research assistant fluent in both languages. All authors read the transcripts, and 
discussed emerging issues.  Thereafter three investigators developed a codebook by 
selecting three transcripts, re-reading them, assigning meaning units to each response 
and codes to each meaning unit. They then met and unified their codes.  
 
Content analysis was used (Graneheim and Lundman 2004, Nelson et al. 2011). All 
transcripts were entered into Atlas Ti software. Thereafter, each response was 
assigned a code. Responses with similar codes were re-categorised under unifying 
sub-themes and themes, following which the themes were listed. The categories were 
then interpreted for their descriptive meaning. The authors also identified descriptive 
quotes representing key themes and an over-arching descriptive theme.   
 
4.7 ETHICAL AND SCIENTIFIC REVIEW 
This study was approved by Makerere University School of Public Health Ethics 
Committee (30
th
 June 2011), the Swedish Regional Ethics Board (Stockholm) (Diary 
Number 2010/2049-31/2) and the Uganda National Council of Science and 
Technology. Permission was also obtained from the HDSS management. Each 
participant consented to be involved, and identification was anonymous. 
 
The main ethical challenge arising out of this study was the required follow-up care 
for the people with unconfirmed type 2 diabetes, pre-diabetes and hypertension 
identified in the data collection, since the initial screening tests were not 
confirmatory. All these participants were referred to Iganga District Hospital‟s 
diabetes clinic. A memorandum of understanding was signed with the hospital 
management and meetings held with the diabetes clinic team to discuss the 
implications of the additional client load. Additional logistics to facilitate follow-up 
of the referred participants were provided by the study management to the diabetes 
clinic. All people suspected to have type 2 diabetes, pre-diabetes or hypertension 
were provided with counselling about their condition, the need to visit the diabetes 
clinic for further evaluation, and their lifestyle. They were each given a referral letter 
in which findings from their preliminary assessment were recorded. 
 
Other ethical challenges arose from a few participants initially denying their results, 
hence requiring follow-up counselling, participation in multiple studies, requiring 
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consent for each study and the worry that resulted from telling some participants that 
they had suspected type 2 diabetes. These challenges were mitigated by providing 
additional counselling to the affected participants. 
 
4.8 SUMMARY OF THE METHODS 
Table 3 below provides a summary of the methods used for the different studies: 
 
Table 3: Summary of the studies and methods used 
Design Timing Data Collection Variables Analysis 
I.  
Cross-
sectional 
population-
based 
(n=1656; 
35-60 years) 
 
May-
June 
2011 
Physical 
Measurements 
 Height, Weight and BMI 
 Waist circumference,  
 Blood Pressure 
Prevalence of  
overweight & 
hypertension 
Behavioral 
questionnaire 
adapted from 
validated tools 
 Demographics 
 7 Socio-behavioral 
factors: Family history, 
stress, Physical activity, 
Tobacco, Alcohol, 
Knowledge, Diet 
 Logistic regression for 
factors associated with 
overweight & 
hypertension 
II. Cross-
sectional 
Cluster 
Survey 
(n=1497;  
Age 35-60) 
March-
April 
2012 
Physical 
Measurements  
 Same as Study I 
 FPG on appointment after 
fasting (On-call Plus, 
Acon Rapid Kits) 
Prevalence of abnormal 
glucose regulation 
(AGR) 
Un-detected disease 
Behavioral 
questionnaire  
 Same as Study I Modified Poisson 
regression for factors 
associated with AGR 
Costs  Additional Direct Medical 
Cost of screening 
Cost/person with AGR 
detected 
III. Cross-
sectional 
comparative 
(n=795; 35-
60; nested in 
II) 
March-
April 
2012 
Physical 
measurements 
in a sub-sample 
 Same as study I 
 FPG from study II 
 HbA1c (A1c Now®, 
Bayer AG) 
 Cut-offs by WHO & 
ADA 
% Agreement in 
classifying diabetes & 
hyperglycemia (general 
and among people with 
risk factors) 
ROC: Performance of 
HbA1c referenced to 
FPG 
Qualitative  Feasibility of the two tests Comparing feasibility 
IV. 
Qualitative; 
12 FGDs of 
8 people 
each 
 
May 
2013 
FGDs of 
persons with 
probable 
diabetes, pre-
diabetes and 
normal but 
obese persons 
 Perceptions on:  
o Severity of diabetes 
o Obesity  
o Healthy diet 
o Physical activity  
o Self-monitoring 
Content analysis by a 
multi-disciplinary team 
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5 RESULTS 
 
5.1 PREVALENCE OF RISK FACTORS FOR TYPE 2 DIABETES (I) 
This section sets the context for understanding type 2 diabetes by showing the extent 
to which risk factors exist among people aged 35 to 60 years in the community. It 
also identifies the modifiable risk factors and how these relate with two important risk 
factors – overweight and hypertension. 
 
Prevalence of overweight, obesity and hypertension in people aged 35-60 years 
The mean BMI was 22 (Standard Deviation (SD) = 4.1). Table 4 summarizes key 
findings on the prevalence of overweight and hypertension by sex:  
 
Table 4: Prevalence of overweight, obesity and hypertension in people aged 35-60 years 
Characteristic Men Women Overall p-value 
n % n % % 
BMI categories:       
Less than 18.5 142 17.6 124 14.6  16.1 Ref 
18.5 – 24.99 585 72.7 513 60.3 66.3 0.975 
25 – 29.99 60 7.5 144 16.9 12.3 <0.001 
30 +  18 2.2 70 8.2 5.3 <0.001 
Waist circumference:       
Normal 755 93.8 455 53.5 73.0 Ref 
Moderately elevated 39 4.8 179 21.0 13.2 <0.001 
Substantially elevated 11 1.4 217 24.5 13.8 <0.001 
Blood pressure:       
Normal or low 214 26.6 339 39.8 33.4 Ref 
Pre-hypertensive 424 52.7 339 39.8 46.1 <0.001 
Hypertensive or on treatment 167 20.7 173 20.4 20.5 0.356 
Both Hypertensive and Overweight:       
No 772 95.9 783 92.0 93.9 Ref 
Yes 33 4.1  68 8.0 6.1 0.001 
Family history of diabetes       
No 713 88.6 746 87.2 1454 Ref 
Yes 92 11.4 110 12.9 202 0.389 
Ref=Reference category  
 
Eighteen percent of participants were found to be overweight, with a marked disparity 
between sexes (25.2% of women vs. 9.7% of men, p<0.001). 5.3% were obese (8.3% 
of women vs. 2.2% of men, p<0.001) (Table 4). Women were four times more likely 
to be overweight compared to men (OR 3.7; 95% CI 2.7-5.1). Compared to 
participants aged 35-39, those aged 45-49 and 50-54 years were more likely to be 
overweight (OR 1.6; 95% CI 1.1-2.4; OR 1.8; 95% CI 1.1-2.8 respectively). 
Prevalence of abdominal obesity was 27%, with a much wider disparity between 
sexes (47% in women vs. 6% in men, p<0.001) (Table 4). A family history of 
diabetes was found in 12% of participants. Participants with a family history of 
diabetes were 1.8 times more likely to be overweight (OR 1.8; 95% CI 1.3-2.5).  
 
The prevalence of hypertension was 20.5%, with no difference between sexes (OR 
1.0; 95% CI 0.8-1.2). Prevalence of pre-hypertension was 46%. 50% of participants 
with hypertension were not on treatment. Being hypertensive was associated with age 
and residence. Compared with the age-group 35-39 years, statistically significant 
differences in the likelihood of hypertension were observed from the age-group 45-49 
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years and above. Participants in the age-group 55-60 years were about 5 times more 
likely to be hypertensive than those in the age-group 35-39 (OR 4.5; 95% CI 2.9-7.0). 
Peri-urban dwellers were more likely to be hypertensive compared to rural dwellers 
(OR 2.4; 95% CI 1.6-3.7). Socio-economic status, occupation, level of education and 
family history of diabetes were not significantly associated with hypertension. 
 
Prevalence of modifiable behavioural risk factors for type 2 diabetes 
Table 5 below summarizes key findings on the prevalence of modifiable socio-
behavioural characteristics associated with type 2 diabetes. 
 
Table 5: Prevalence of modifiable socio-behavioral risk factors for type 2 diabetes 
Characteristic All 
(%) 
n= 
1656 
By sex By residence 
Men 
(%) 
n=805 
Women 
(%) 
n=856 
OR p-Value Rural 
(%) 
n=1352 
Peri-
Urban 
n=264 
OR p-Value 
WHO  physical 
activity threshold: 
 
 
   
 
   
Does not attain 15.9 15.0 14.1 1  9.2 45.5 1  
Attains 84.1 85.0 85.9 1.2 0.612 90.8 54.5 0.1 <0.001 
Stress level:          
Low 43.6 47.9 39.6 1  41.9 53.1 1  
Moderate 21.2 32.8 48.9 1.8 <0.001 42.2 35.6 0.7 0.010 
High 15.2 19.3 11.6 0.7 0.043 15.9 11.3 0.6 0.013 
Knowledge about 
lifestyle diseases: 
         
Inadequate 65.4 61.2 69.2 1  66.4 59.9 1  
Adequate 34.6 38.8 30.8 0.7 0.001 33.7 40.1 1.3 0.063 
Tobacco user:          
No 94.1 88.3 99.4 1  93.4 98.2 1  
Yes 5.9 11.7 0.6 0.1 <0.001 6.6 1.8 0.3 0.009 
Harmful alcohol 
taker: 
         
No 95.3 91.6 98.7 1  95.8 92.8 1  
Yes 4.7 8.4 1.3 0.1 <0.001 4.2 7.2 1.8 0.056 
Dietary diversity:          
Low 21.6 21.4 21.9 1  19.6 33.3 1  
Moderate 68.2 66.5 69.7 1.0 0.854 70.4 15.4 0.5 <0.001 
High 10.2 12.1 8.4 0.7 0.050 10.0 11.3 0.7 0.111 
 
 
84% of participants met the WHO minimum recommended physical activity 
threshold. 15% showed high levels of stress. Only 35% had adequate knowledge 
about lifestyle diseases and only 10% had sufficiently diverse diets (Table 5). The 
overrall prevalence of smoking and dangerous alcohol taking were very low. Women 
had significantly less knowledge about lifestyle diseases (OR 0.7; p=0.001) but men 
were 10 times more likely to smoke and engage in harmful alcohol taking. Men were 
also more likely to have high stress levels although women predominated in moderate 
stress. Peri-urban dwellers were more likely not to achieve the recommended physical 
activity threshold and to engage in harmful alcohol taking compared to rural dwellers. 
On the other hand, rural residents had less awareness about lifestyle diseases, higher 
stress levels and higher use of tobacco compared to peri-urban dwellers (Table 5). 
 
Modifiable factors associated with overweight and hypertension 
Modifiable socio-behavioural factors found to be associated with being overweight 
included residence, socio-economic status, hypertension, physical activity, knowledge 
about diabetes, and dietary diversity. Peri-urban residents were two times more likely 
to be overweight compared to rural residents (OR 2.1; 95% CI 1.46-3.01). 
Participants in the highest SES quintile were four times more likely to be overweight 
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than those in the lowest quintile (OR 4.1; 95% CI 2.4-7.0). Participants who met the 
WHO minimum threshold for physical activity were significantly less likely to be 
overweight than those who did not (OR 0.7; 95% CI 0.5-0.9). Participants with 
moderate dietary diversity were also less likely to be overweight than those with low 
dietary diversity (OR 0.7; 95% CI 0.5-0.9). Paradoxically, people who knew more 
about diabetes were more likely to be overweight (OR 2.0; 95% CI 1.0-3.7).  
 
Except for knowledge about life-style diseases and overweight, none of the other 
modifiable behavioural characteristics were associated with being hypertensive. 
Stratified analysis shows that not only was there an association between being 
hypertensive and being overweight (OR 2.5, 95% CI 1.9-3.3), but the association was 
only statistically significant among rural residents (OR 2.9, p<0.001) and not peri-
urban residents (OR 1.3, p=0.363) (p for homogeneity of OR=0.013). Place of 
residence is therefore an effect-modifier of the relationship between being 
hypertensive and being overweight. As with BMI, participants who knew more about 
lifestyle diseases were more likely to be hypertensive.  
 
Summary of key findings 
 
18% of the people aged 35-60 in this predominantly rural setting are overweight. 
Women were substantially more likely to be overweight and obese compared to 
men. Overweight is also associated with peri-urban residence, insufficient physical 
activity and low dietary diversity. About 21% of the people aged 35-60 are 
hypertensive and 46% have pre-hypertension. 50% of people with hypertension were 
not on treatment. Hypertension is associated with peri-urban residence, age, and 
being overweight. Only 35% of participants had comprehensive knowledge about 
life-style diseases. 
 
With this background information on risk factors, the next step was to assess the 
prevalence of AGR to clarify its magnitude, its socio-behavioural correlates and the 
direct medical costs of screening to detect high risk persons. 
 
 
5.2 PREVALENCE AND CORRELATES OF ABNORMAL GLUCOSE 
REGULATION (II) 
Prevalence of AGR and awareness about diabetes status 
The mean FPG value for people aged 35-60 years in this setting was 5.3mmol L
-1
 
(Range 2.5-29.9mmol L
-1
). The prevalence of diabetes was 7.4% (95%CI 6.1-8.8). 
This included 82 participants with FPG ≥7mmol L-1 (5.5%) and 28 on diabetes 
treatment but with FPG <7.0mmol L
-1
 (1.9%). Using WHO criteria, the prevalence of 
pre-diabetes was 8.6% (95%CI 7.3-10.2). The ADA cut-offs resulted in a higher 
prevalence of pre-diabetes (20.2%; 95%CI 17.5-22.9).  Prevalence of diabetes and the 
ratio of diabetes: pre-diabetes increases with increasing 5 year age-categories within 
the age-group studied but prevalence of AGR levels-off from 50-60 years (Figure 4).  
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Figure 4: Prevalence of abnormal glucose regulation by age category 
 
Among the 82 participants with FPG levels in the range classified as diabetes, only 16 
(19.5%) were aware of their status. Overall, only 44 of the 110 participants (40%) 
who had diabetes were aware of their status. Among 44 participants on diabetes 
treatment, only 28 (63.6%) had FPG levels <7 mmol L
-1
. 
 
Factors associated with AGR among people aged 35-60 years  
Table 6 shows factors associated with AGR among people aged 35-60 years.  
 
Table 6: Factors associated with Abnormal Glucose Regulation among people aged 35-60 
years 
Factor Category   n  % AGR PRR APRR† P-value 
Occupation Subsistence 171 9.4 1.0 1.0  
Traders 281 16.4 1.1[0.81-1.50] 1.0[0.75-1.37] 0.932 
Formal salaried 97 19.6 1.3[0.87-2.07] 1.2[0.79-1.94] 0.357 
Mechanic 925 14.6 0.6[0.38-1.02] 0.6[0.37-0.97] 0.038 
BMI 18.5-24.9 988 14.2 1.0  1.0  
<18.5 240 8.8 0.6[0.40-0.95] 0.6[0.40-0.94] 0.027 
25-29.9 189 17.5 1.2[0.87-1.74] 1.2[0.83-1.67] 0.349 
30+ 80 27.5 1.9[1.31-2.86] 1.9[1.30-2.83] 0.001 
Physical 
activity 
Insufficient 213 21.1 1.0 1.0 
 Attains standard 1261 13.6 0.6[0.48-0.87] 0.6[0.44-0.83] 0.002 
Dietary 
diversity 
Low 318 18.2 1.0 1.0 
 Moderate 1005 14.2 0.8[0.59-1.03] 0.8[0.59-1.03] 0.083 
High 151 9.9 0.6[0.32-0.94] 0.5[0.32-0.93] 0.026 
PRR=Unadjusted Prevalence Rate Ratio; APRR=Adjusted Prevalence Rate Ratio (†Adjusted for 
residence, age, occupation, family history of diabetes, BMI, physical activity and dietary diversity) 
 
 
The prevalence of AGR was twice higher in obese people compared to those with a 
normal BMI (APRR 1.9, 95% CI 1.3-2.8).  AGR did not differ significantly between 
participants in the overweight category and those with a normal BMI (APRR1.2, 95% 
CI 0.8-1.7). One in 10 overweight people (11%) and one in five obese people (21%) 
had diabetes. Sufficient physical activity and higher dietary were associated with a 
significantly lower likelihood of AGR (APRR 0.6, 95% CI 0.4-0.8; APRR 0.5, 95% 
CI 0.3-0.9 respectively) (Table 6). While the estimated prevalence of type 2 diabetes 
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is 5% among people aged 35-60 years, it rises to 12% among those aged 50-54 and 
averages 7% in the 40 year age-groups.  
 
AGR was significantly lower among people employed as mechanics compared to 
subsistence farmers (APRR 0.6, 95% CI 0.3-0.9). Further analysis shows that 
although the majority of our study population achieves the recommended physical 
activity threshold, substantially more mechanics achieve this threshold (92%) 
compared with subsistence farmers (80%). Physical activity is therefore an 
intervening variable in the relationship between occupation and AGR. Although 
residence was not significantly associated with AGR, adjusting for physical activity 
resulted in a 40% lower likelihood of AGR among participants from peri-urban 
villages compared with rural dwellers (APRR 0.6, 95% CI 0.4-0.9). Therefore 
physical activity is a confounder of the relationship between place of residence and 
AGR. There was no significant association between sex, age group, level of 
education, socio-economic status, hypertension, tobacco use and harmful alcohol use 
with AGR. 
 
Cost per high risk individual discovered through screening 
The total annualized direct medical costs of screening all people aged 35-60 years in 
the district over two years, assuming that 12 health centres are involved, was 16,577 
US$. Therefore, the cost per person screened is US$0.53 per year. At the current level 
of prevalence, the cost of detecting one person with AGR in this age-group is 
estimated at US$3.7 with WHO criteria and US$2.0 with ADA criteria. If screening is 
targeted to overweight persons only, the cost of detecting one person with AGR in 
this age-group is about US$3.0 with WHO criteria and US$1.7 with ADA criteria. 
 
Summary of key findings 
 
The prevalence of diabetes was 7.4% while pre-diabetes was 9% with WHO and 
20% with ADA criteria. 60% of people with suspected diabetes are not aware. At the 
current level of diabetes prevalence the direct medical cost of screening for AGR in 
people aged 35-60 is 0.53 US Dollars; the cost per high risk person detected is 2US$ 
using ADA cut-offs and 3.7 US$ using WHO criteria. Three modifiable factors 
found to be significantly associated with AGR were being obese, insufficient 
physical activity and inadequate dietary diversity 
 
Because of the substantial prevalence of AGR in study II, and the high levels of 
undetected diabetes, further evaluation of the utility of possible screening and 
diagnostic tools for type 2 diabetes was necessary. Study III therefore assessed the 
level of agreement between two rapid tests to gauge their utility in this setting. 
 
 
5.3 UTILITY OF FPG AND HbA1C TESTS IN PRIMARY CARE 
SCREENING (III) 
Agreement between FPG and HbA1C in classifying diabetes status and AGR 
There was a marked disparity in AGR prevalence determined by the two tests. FPG 
classified 4.8% of participants in the range of diabetes while 21.8% and 10.1% were 
in the range for pre-diabetes (using ADA and WHO criteria respectively).  Based on 
HbA1C, 11.3% were in the diabetes range while 26.4% were in the range for pre-
diabetes. Table 7 shows the percentage agreement between the two rapid tests:  
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Table 7: Percentage agreement between FPG and HbA1C in classifying diabetes and AGR 
status 
Category Agreement in classifying 
diabetes 
[HBA1c outcomes at given 
outcomes of FPG] 
Agreement in classifying 
AGR 
[HBA1c outcomes at given 
outcomes of FPG] 
In +Ves In –Ves  Kappa In +Ves In –Ves  Kappa 
In the entire sample (n=795) 20% 97% 23% 21% 89% 11% 
Among  hypertensive (n=159)  28% 99% 35% 21% 94% 14% 
Among overweight people (n=124) 39% 98% 45% 28% 87% 14% 
Both overweight & hypertensive (n=42) 50% 100% 59% 32% 91% 15% 
Among obese persons only (n=42) 62% 100% 69% 48% 100% 43% 
 
 
Overall agreement between the two rapid tests in classifying diabetes status was low 
(Kappa=22.9). Agreement was even much lower in classifying AGR (Kappa=10.6% 
with WHO cut-off and 11.0% with ADA cut-off for FPG). Among persons classified 
as having diabetes by the FPG test, the HbA1C test provides a similar classification for 
53% of them. Likewise, among persons classified as having diabetes by HbA1C, the 
FPG test only provides a similar classification for 20% (Table 7). Based on the ROC 
curves, the performance of HbA1C in predicting FPG-defined diabetes status was 
moderate (AUC=0.75; 95% CI 0.65-0.85) (Figure 5). ROC curve analysis shows that 
BMI has lower but moderate performance in predicting diabetes-defining FPG levels 
(AUC=0.66; 95% CI 0.57-0.75) (Figure 5). The same analysis shows that the 
performance of HbA1C in predicting FPG defined AGR was very low (AUC=0.59; 
95% CI 0.54-0.63) (Figure 5). Correlation analysis shows too that although there is 
substantial linear correlation between the two tests‟ measurements (p<0.001), the 
correlation explains a very low threshold of the variability between the two tests 
(R
2
=16%). 
 
Despite the sub-optimal agreement in defining diabetes and AGR, there is high 
agreement among the negatives. Among persons classified as not having diabetes by 
the FPG test, the HbA1C test too classifies 91% of them as not having diabetes. 
Likewise, among persons classified as not having diabetes based on HbA1C, the FPG 
test too classifies 97% of them as not having diabetes. Similarly, agreement among 
the negative test results in classifying AGR at given cut-offs for FPG was good 
(89%). 
 
Similarly, agreement between FPG and HbA1C rapid tests in classifying diabetes 
status is higher when the tests are conducted among individuals with risk factors for 
type 2 diabetes. A gradient is observed across risk factors. While a Kappa Statistic of 
22.9 is obtained when the two tests are applied to the entire sample, a Kappa of 34.9 
is obtained for hypertensive persons, 45.4 for overweight persons, 58.8 for persons 
who are both overweight and hypertensive and 68.8 for obese persons (Table 7). ROC 
analysis shows high performance of HbA1C in predicting FPG-defined diabetes status 
among overweight persons (AUC 0.90; 95% CI 0.76-1.00) and obese persons (AUC 
0.98; 95% CI 0.94-1.00) (Figure 5). The strength of the correlation between FPG and 
HbA1C is higher among people with risk factors (R
2
=69% among obese persons). 
However, agreement between FPG and HbA1C in classifying AGR does not improve 
among people with risk factors, except in obese people (Kappa=42.9) (Table 7).  
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a: Relationship between FPG-defined 
diabetes status with HbA1C values/ BMI 
 
(HBA1C: AUC=0.75; 95% CI 0.65-0.85) 
(BMI: AUC=0.66; 95% CI 0.57-0.75) 
b: Relationship between FPG-defined 
AGR and HbA1C values 
 
(AUC=0.59; 95% CI 0.54-0.63) 
 
c: Relationship between FPG-defined 
diabetes status and HbA1C values among 
overweight persons 
 
(AUC 0.90; 95% CI 0.76-1.00) 
d: Relationship between FPG-defined 
diabetes status and HbA1C values 
among obese persons 
 
(AUC 0.98; 95% CI 0.94-1.00) 
 
Figure 5: Receiver Operating Characteristic (ROC) curves for the relationship between 
FPG-defined diabetes status and abnormal glucose regulation (AGR) status and HbA1C 
 
Feasibility of rapid tests in primary care 
According to the research assistants, the devices used in both FPG and HbA1C 
measurements were easy to use and nurses could administer the tests. The FPG test 
took a mean of four minutes to perform while the HbA1C test took a mean of nine 
minutes. Some challenges were observed. For the FPG test, some participants did not 
comply with fasting, resulting in re-scheduled appointments. The FPG test was also 
associated with errors but these were reported to be much less frequent compared to 
HbA1C. The HbA1C procedure was viewed as complicated. It required more steps in 
preparation of the sample. HbA1C also generated more quality control errors than the 
FPG. It also required precise timing between steps, and a test could be wasted by 
taking too long or too short between some steps. HbA1C required longer practice 
before the teams could master the steps. The HbA1C devices failed to operate 
whenever the room temperature exceeded 28
o
C, which was common after 11.30 am 
in Iganga at the time of study III. HbA1C was associated with a 10% wastage rate 
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compared to only 2% for the FPG. Other causes of failure of the HbA1C included 
accidental contamination with moisture and dust. By design, the HbA1C device was 
tagged to a batch of only 10 tests after which it was auto-disabled. 
 
Summary of key findings 
 
FPG and HbA1C have moderate agreement in classifying diabetes but low agreement 
for abnormal glucose regulation. However, their agreement is high among those 
testing negative with either test, and in people with risk factors for type 2 diabetes 
especially obese persons. Nurses are capable of administering both rapid tests 
although FPG is more practical than HbA1C. 
 
Having affirmed that prevalence of type 2 diabetes related risk factors is substantial 
and that it is possible to identify high risk people using rapid tests or risk factors, it 
was necessary to know how people with risk factors perceive type 2 diabetes and 
preventive lifestyles. Study IV therefore explored these perceptions. 
 
 
5.4 PERCEPTIONS ABOUT DIABETES, OBESITY AND HEALTHY 
LIFESTYLES (IV) 
Perceptions on severity of type 2 diabetes  
Participants from the majority of the FGDs viewed type 2 diabetes as a „very severe 
disease‟. Their explanations were in two main categories: Some said it is severe 
because it „cannot be cured‟ while others cited its consequences to affected people as 
the reason for its severity. Incurability was qualified by stating that „it kills‟ and that 
it requires „life-long treatment‟.  
 
“We know it (diabetes) is a very severe disease. It weakens you and then kills 
you. It eats you up till you are disabled. I have never seen a person with 
diabetes who has cured.” (Male FGD, with diabetes, rural) 
 
They explained that people with diabetes require „injections‟ before every meal and 
that they are forbidden from eating some foods like sugar, rice and oil.  
 
“Diabetes will require you not to eat certain types of foods.... You always first 
have to inject yourself then you eat. If you miss treatment for a day, you can 
even die. Even if you treat it, it can still kill you (Female FGD, obese, rural) 
 
Among participants who labelled type 2 diabetes as a very severe disease because of 
its consequences, female participants were concerned about wide-ranging health 
effects of the disease while male participants were more concerned about the effect of 
type 2 diabetes on sexual performance, or „manhood‟.   
 
“Diabetes leads to many complications including loss of eye sight and heart 
disease. It makes people weak. They develop pain all the time; they don‟t get 
any peace” (Female FGD, with pre-diabetes, rural) 
 
“Diabetes weakens a man‟s manhood; it reduces sexual performance by 
making men impotent and infertile. The man no longer satisfies the partner‟s 
needs; the wife might run away or engage in extra-marital affairs” (Male 
FGD, with diabetes, rural) 
 37 
 
 
Both male and female FGD participants were equally concerned about the economic 
effects of diabetes including failure to work and expensive long-term treatment.  
 
Views about body weight and obesity 
There was a marked difference in perceptions about obesity between FGDs of people 
with probable type 2 diabetes and those without. Participants with probable type 2 
diabetes viewed obesity negatively, associating it with disability and many illnesses. 
 
“Before I gained this weight I had no problem; now I have many 
complications – (high blood) pressure and joint problems. When someone is 
overweight, her energy and ability reduce. Weight is sickness” (Female FGD, 
with diabetes, peri-urban) 
 
However, among participants without diabetes, obesity is associated with wellness: 
„eating well‟, „high social standing‟ and „success‟. The local word for an obese person 
(„omuba‟) also means „a very important person‟. 
 
“In Busoga here when someone is big, they think that person has money. They 
call them „omugaiga‟ (the rich one) or „Byandaala‟ (the well-off); if you are a 
woman, they call you „Hajjati‟, a show of respect. When you go to a function 
or church they give you a front seat” (Female FGD with pre-diabetes, rural) 
 
Many obese participants said that weight gain is natural and cannot be controlled. 
Some attributed it to „having large bones‟. Participants from a majority of the FGDs 
of people without diabetes said that weight loss is stigmatized. When one loses 
weight, people think he/she is very sick, suffers from HIV or has lost wealth. 
 
“If you are big and you lose weight people think you have HIV. When they see 
someone losing weight they say „that person is sick‟”. (Female FGD, with 
pre-diabetes, rural) 
 
“If you lose weight people think you no longer have money. We now we have 
micro-finance - people may think that you have failed to pay a loan...” (Male 
FGD obese, peri-urban) 
 
Perceptions about healthy diet 
To rural participants „unhealthy foods‟ mean „foods that taste sweet, sugary, or 
contain a lot of sugar‟, while peri-urban participants cite both sugary foods and „fried 
foods‟ as unhealthy. Peri-urban participants widely believed that as long as meat is 
only boiled but not fried, its fat content is low. Rural participants also believed that 
because of their sweet taste, sweet-potatoes are a high risk food, yet they are the 
staple food in Busoga region. 
 
“In Busoga here, one type of food we always eat is sweet potatoes; but they 
have a lot of sugar and I think they contribute to the high rate of diabetes.” 
(Male FGD, obese, rural) 
 
Participants were concerned about several barriers to a healthy balanced diet. Some 
said that cessation of high risk foods is not practical because they have the best taste.  
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“You see the things they advise us against are also the tastiest - it is difficult 
to eat un-fried beans. Without sugar or salt, you will not enjoy life” (Female 
FGD, with pre-diabetes, peri-urban) 
 
Poverty and inability to afford some foods was mentioned as a key barrier to a 
balanced diet. Protein rich foods were cited as the most expensive. Some participants 
also linked non-affordability of food to having large families. 
 
“Eating well depends on income; when you have money you can eat chicken, 
fish and eggs; you cannot buy only half a kilo of meat to serve ten people” 
(Male FGD, with diabetes, Urban)  
 
Regarding access to food, majority of FGDs said that a range of foods are available in 
Busoga region in all food categories. However, most FGDs said that it was not 
possible for households to produce all the necessary foods.  
 
“The main food we grow is sweet potatoes. We face a big problem finding the 
money to buy other food; we do not have banana or rice plantations. 
Sometimes all you have is maize flour.” (Female FGD, with diabetes, rural) 
 
Several participants said that adjustments for healthy diets are feasible. However, 
there was a consistent view that „change involved sacrificing a good life‟ for a 
„controlled‟ life. „Eating what one loves‟ and „eating tasty food‟ was viewed as 
„having a good life‟. Most participants felt that slowly reducing the quantity and 
frequency of risky foods was more feasible than stopping them abruptly.  
 
“Change means sacrificing a good life... You find problems leaving foods that 
you enjoy. It is only possible if you reduce slowly.” (Male FGD, with pre-
diabetes, peri-urban) 
 
Perceptions about physical activity 
Participants defined physical activity as „not sitting in one place‟ but „keeping oneself 
busy‟. The majority said that the most feasible form of physical activity was domestic 
work. The range of possible chores suggested was diverse, including gardening, brick 
making, tending to domestic animals, fetching water, splitting firewood, bush 
clearing, and pounding food among rural residents, while washing, cooking, and 
walking or cycling to the market were cited for peri-urban residents. There was a 
consistent view that physical activity increments should be nuanced on familiar forms 
of work. 
 
“Change is possible but in ways familiar to us. Everyone is involved in some 
domestic work; for me I think the main issue is how much you do…” (Male 
FGD, with diabetes, rural) 
 
Most participants believe that formal exercises are not feasible for adults in their 
context, unless they were part of other routine chores or unless someone had diabetes. 
 
“It‟s impossible for people to wake up and run. Apart from sportsmen, I have 
never seen anyone leave his home to go running! May be the children - that is 
the way they behave; but for an adult to run…!” (All laugh) (Male FGD, with 
pre-diabetes, peri-urban)  
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Instead, increased walking and cycling were proposed as more feasible alternatives. 
Several participants said it is feasible to achieve 30 minutes of physical activity daily. 
However, there was a consistent view that physical activity increments had to be slow 
because they were not used to them and they meant a major adjustment in their life. 
 
Perceptions about monitoring personal health 
Most participants said that it was possible to regularly monitor their health. However, 
there were different interpretations of how this can be done. Some said they could 
monitor „how they feel‟, and that „one could feel that he/she is unhealthy‟. Others said 
they could weigh themselves regularly while others said they could go to the health 
facilities for periodic check-ups. Some barriers to going for health facility check-ups 
were cited including transport, long distances, work commitments, and not knowing 
what the check-up entails. Facility related concerns included: waiting times, service 
charges and uncertainly about whether they would get the service when not ill. 
 
“When we are ill, health workers only ask questions and prescribe 
medications hurriedly without tests; how will they test us when we have no 
illness?”(Female FGD, obese, rural) 
 
Participants also expressed the fear of discovering „health problems‟ that one could 
tolerate without knowing them which would lead them to worry. 
 
Summary of key findings 
 
Type 2 diabetes is perceived to be a very severe disease but there are gender 
differences in explanations: Women were more concerned about the suffering it 
causes while men were mostly concerned about its effects on sexual performance or 
„manhood‟.  The widespread perception that type 2 diabetes is a severe disease is 
however in contrast to people‟s perceptions about preventive measures. Among 
participants without type 2 diabetes, obesity is associated with „success‟ and 
„wellness‟ while weight loss is stigmatised. Adjustment in diet and physical activity 
are perceived as feasible provided the recommended options are accessible, that 
changes are introduced gradually, and that proposed activities are familiar to them. 
Change is perceived as „sacrificing a good life‟. 
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6 DISCUSSION 
 
This thesis is an exploration of type 2 diabetes in a predominantly rural setting in 
Uganda. Not only was the prevalence of overweight and hypertension substantial in 
people aged 35-60years, but rates of abnormal glucose regulation were high, amidst 
low awareness about lifestyle diseases (I, II). Gender and socio-economic disparities 
in the distribution of risk factors were observed (I, IV). Obesity, insufficient physical 
activity and unhealthy diets are highlighted as key correlates of abnormal glucose 
regulation. The direct medical cost of opportunistic screening for abnormal glucose 
regulation is US$0.53 per person, translating to US$ 2 per high risk person detected 
in the age-group studied (II). Although FPG and HbA1C rapid tests have low general 
agreement in classifying diabetes and abnormal glucose regulation, their convergence 
is high among people with risk factors and among negative results (III). Communities 
perceive type 2 diabetes to be a very severe disease, yet they showed low levels of 
enthusiasm to take up preventive lifestyles. The findings from this study highlight 
some important options for integration of NCD prevention and care into the health 
system of a typical low income country.  
 
6.1 RISK FACTORS ARE SUBSTANTIAL AMIDST LOW AWARENESS 
The prevalence of overweight and hypertension is substantial among people aged 35-
60 years in this predominantly rural setting. One in six people (18%) is overweight 
(I). Compared with 11% prevalence of overweight reported from a study in rural 
southern Uganda that included all ages above 12 years (Maher et al. 2011), these 
findings may imply that people aged 35-60 years are more likely to be overweight 
than the general population. This could be attributed to higher sedentariness and 
autonomy over dietary choices in this age-group compared to younger people.  
However, these rates of overweight and obesity are much lower than those reported in 
rural South Africa (Bourne et al. 2002), and in many high-income countries (WHO 
2011c), probably reflecting an earlier stage in the epidemiological transition.  
 
One in five people (21%) had hypertension (I). Several studies have shown that 
hypertension occurs frequently in sub-Saharan Africa (Thorogood et al. 2007, 
Wamala et al. 2009, Oladapo et al. 2010, Maher et al. 2011). The related finding that 
46% had pre-hypertension (I) implies a potential for hypertension in this non-elderly 
age-group to increase. Other risk factors were variable. Obesity (the extreme category 
of overweight), insufficient physical activity, harmful alcohol taking, and smoking 
were low while moderate stress and non-diverse diets were frequent (I).  
 
The occurrence of risk factors is not random (I). Socio-demographic factors 
associated with overweight included sex, residence, age and family history of 
diabetes, while hypertension was associated with age and peri-urban residence (I). 
The link between sex and overweight is likely a gender one because several studies 
show a social desirability of overweight among women in Africa („big is beautiful‟) 
(Maletnlema 2002, Holdsworth et al. 2004, Rguibi and Belahsen 2006, Stern et al. 
2010, Lagerros and Rossner 2013). In study I, a gender analysis shows that women 
had substantially less knowledge about lifestyle diseases, although men were more 
likely to smoke and engage in harmful alcohol taking (I). Analysis by residence 
shows that peri-urban dwellers were less physically active and were more likely to 
engage in harmful alcohol taking compared to rural dwellers. Conversely, rural 
residents had less knowledge about lifestyle diseases and were more likely to smoke 
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(I). The modifiable behavioural correlates of overweight were insufficient physical 
activity and non-diverse diets (I, II). The only modifiable factor found to be 
associated with hypertension (i.e. being overweight) (I) is insufficient to explain the 
substantial prevalence of hypertension in this setting. 
 
Only about one third of surveyed individuals had adequate awareness about lifestyle 
diseases (I). Other studies in Africa have also shown low levels of awareness about 
healthy lifestyles even among people with chronic diseases (Ike et al. 2010, Donkor et 
al. 2014). This finding aligns with evidence from study IV which shows gaps in 
perceptions about risk factors and preventive measures for type 2 diabetes. This 
situation enhances the urgency for awareness creation on healthy lifestyles. In a 
context where health education is mainly pre-occupied with acute infectious 
conditions (Maher et al. 2010, Remais et al. 2013), communities need to be 
„awakened‟ to the reality that type 2 diabetes and related diseases are preventable.  
 
There is critical need for mass awareness raising and behaviour change 
communication about lifestyle diseases and their risk factors. There is a need to 
develop health information that effectively links NCD risk factors to disease, and to 
integrate it into routine health education and promotion activities in primary care. 
Health information is one of the key health system building blocks, cited too by the 
WHO as a „best buy‟ in population level NCD interventions (WHO 2011c). 
Traditional health facility- and outreach-based health education sessions would have 
to be re-oriented and re-organised to integrate education on lifestyle diseases. This 
includes health education in out-patient clinics, wellness clinics like the child health 
and family planning clinics, and the routine integrated prevention outreaches. On a 
larger scale, mass awareness-creation drives using mass media would also be needed 
so that the level of concern about lifestyle diseases is raised nationally. 
 
The significance of the socio-demographic correlates of overweight and hypertension 
is that they inform us which sub-populations to target with specific messages. Peri-
urban residents and people of higher socio-economic status need targeted education. 
In addition, messages are needed to change perceptions about obesity in women. The 
significance of the modifiable risk factors for overweight and hypertension is that 
they clarify the priority content for behaviour change education, including 
overweight, hypertension, insufficient physical activity and unhealthy diets (I, II). We 
also have the opportunity to address smoking and harmful alcohol taking when their 
prevalence is still low (I).  
 
6.2 HIGH PREVALENCE OF ABNORMAL GLUCOSE REGULATION  
Prevalence of abnormal glucose regulation in people aged 35-60 years 
There is a high prevalence of abnormal glucose regulation among people aged 35-60 
years in this predominantly rural setting (II). 7.4% of people aged 35-60 had probable 
type 2 diabetes (II), a prevalence estimate that is ten times higher than that observed 
in another rural setting in southern Uganda (Maher et al. 2011) but the latter survey 
included a wide age range (≥13 years). Akin to the study in southern Uganda, most 
previous studies in sub-Saharan Africa have found the prevalence of AGR to be 
below 2% (Hall et al. 2011) but they too involved wide age ranges including younger 
participants who are at lower risk of type 2 diabetes. The prevalence of pre-diabetes, 
the most-at-risk category for type 2 diabetes was 20% using ADA criteria (II), 
meaning that there are likely three people with pre-diabetes for every person with 
type 2 diabetes. In the age-group studied, prevalence of AGR peaks between 45-55 
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years. The expectation therefore that rural areas in low income countries have very 
low prevalence of AGR and its risk factors is a fallacy if higher risk age-groups are 
considered (I, II). Nambuya and colleagues found that the mean age of new diabetes 
patients seen at Uganda‟s national referral hospital (which mainly serves urban and 
peri-urban districts in central Uganda) was 45 years while the majority of incident 
cases were aged 40-49 (Nambuya et al. 1996).  
 
60% of people with blood sugar levels in the range of suspected type 2 diabetes (II) 
and 50% of those with hypertension (I) were not aware of their status. This finding 
implies that current diagnostic services are unable to detect the majority of people 
with type 2 diabetes in its early stages. Nambuya and colleagues showed that almost 
all new diabetes patients at the national referral hospital in Uganda presented with 
classical symptoms of diabetes and the majority were severely hyperglycaemic, 
implying that diagnosis occurs late (Nambuya et al. 1996). However, other settings in 
sub-Saharan Africa have much higher levels of un-detected diabetes (up to 90%) 
(Kengne et al. 2013b). 
 
These findings have multiple implications on health information and service delivery, 
which are requisite components of an NCD responsive health system: Firstly, for 
countries in earlier stages of the epidemiological transition, crude estimates might 
mask the high prevalence of abnormal glucose regulation in some higher risk socio-
demographic groups. Estimates that are stratified for these groups are therefore 
necessary in planning NCD interventions because they show whom to target with 
scarce resources. In low prevalence countries therefore, NCD surveillance data should 
be disaggregated to show the prevalence in population sub-groups that are likely to be 
at higher risk – people aged 35-60 are one such group (II).  
 
Secondly, the high prevalence of abnormal glucose regulation (II) and hypertension 
(I) is further evidence of the need to strengthen secondary care for chronic diseases, 
including diagnosis, treatment and follow-up. As Uganda‟s population ages due to 
increasing life expectancy, the burden of diabetes and CVDs is likely to increase. 
Because most people with type 2 diabetes are not aware of their status, there is also 
potential for new diabetes cases seeking care to increase even without an overrall 
increase in type 2 diabetes prevalence, as people get more aware about the disease. 
The number of health centres with the capacity to diagnose and treat diabetes and 
hypertension should be increased. Availability of essential drugs for both diabetes and 
hypertension (including insulin, oral hypoglycaemic drugs and anti-hypertensive 
drugs) should be improved. Capacity for follow up care also needs to be developed by 
availing the logistics to facilitate follow-up of patients and most-at-risk persons, re-
organising the existing outpatient services to integrate follow-up activities and re-
orienting the health workers on chronic care. 
 
Mass screening would raise major service delivery and ethical challenges 
Integration of opportunistic screening for type 2 diabetes in primary care has been 
widely reviewed but the evidence of its feasibility is equivocal. Many controlled trials 
show that early detection is efficacious while others show that it is only efficacious 
when lifestyle interventions are intensive (Janssens et al. 2007, Waugh et al. 2007, 
Beaglehole et al. 2008, Maher et al. 2010, Allotey et al. 2011). However, translational 
studies from controlled environments to the „real world‟ are lacking (Simmons et al. 
2010), more so in sub-Saharan Africa. The value of opportunistic screening for AGR 
and hypertension in low income countries is therefore uncertain.  
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Since one quarter of the surveyed population aged 35-60 years in study II was found 
to have abnormal glucose regulation (II) and one fifth had hypertension (I), mass 
opportunistic screening for AGR and hypertension is impractical in this setting given 
that the health system is currently unable to treat, counsel and follow up all the people 
with risk factors and those with disease that would be identified. The upsurge in new 
cases in the few health facilities that offer diabetes care would no doubt over-burden 
them, yet they already face many challenges from under-staffing and lack of essential 
drugs.  
 
Opportunistic screening would also have implications on health financing, one of the 
fundamental health system building blocks. According to study II, it costs US$0.53 to 
screen one person for abnormal glucose regulation, and US$2 to detect one high risk 
person. Many countries in sub-Saharan Africa cannot afford such costs for one 
disease condition in a section of the population. Uganda‟s government spends about 
US$6 per capita on health (WHO 2009), and an addition of US$0.53 per person aged 
35-60 years (13.5% of the population) would translate into a marginal investment of 
US$0.07 per capita for early detection of type 2 diabetes alone. Moreover, these are 
direct medical costs only, for one service – screening – and they do not include the 
costs of lifelong care, out-of-pocket expenditures like transport, clients time and 
health worker effort. Private expenditure on health in Uganda is estimated at US$24 
per capita (WHO 2009) and families may not be capable of taking on additional costs. 
Mass opportunistic screening also has the potential to disrupt other services.   
 
Instead of mass opportunistic screening for adults, low income countries should 
consider a two stage risk assessment approach in which only people who fulfil some 
socio-behavioural risk based criteria undergo more rigorous evaluation with blood 
tests. Possible first stage evaluation criteria shall be discussed in the next section. 
However, the utility of mass opportunistic screening would only be fully known if the 
hidden costs of late detection of type 2 diabetes and hypertension are determined.  
 
6.3 RISK STRATIFICATION 
Population approach vs. high risk approach 
A key challenge for NCD programs in low income countries is whether to focus on 
population level measures or the high risk individual. While mass approaches are 
often needed for mass disease, they offer little benefit to the high risk individual 
(Rose 1981, Waugh et al. 2007). Conversely, individual approaches would have 
maximal benefit on the individual but may not impact on population level risk (Rose 
1981, Peters 2013). Except for recent evidence from the national cardiovascular risk 
reduction program in Finland (Rautio et al. 2012), the efficacy of mass population 
interventions remains equivocal (Johansson et al. 2009, Simmons et al. 2010), yet 
they are necessary for mass awareness creation. National level regulation of tobacco, 
alcohol and food has also been highlighted as a best-buy for NCD prevention (WHO 
2011c). On the other hand, high risk approaches have been shown to be cost effective 
in several interventions, when targeted to the most-at-risk persons (Mendis et al. 
2004, Waugh et al. 2007). However, most of these studies were conducted in 
controlled conditions and in high income countries, where the prevalence of risk 
factors is generally higher than in low income countries. 
 
Study I, II and IV suggest the need to balance both population and high risk 
approaches. On one hand, the low levels of awareness about lifestyle diseases amidst 
substantial prevalence of risk factors (I) suggests that mass health education is 
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necessary. To deal with older most-at-risk persons only would mean ignoring a larger 
population potentially exposed for several years to lifestyle risks that often start 
earlier in life and progressively lead to the most-at-risk state. Conversely, the high 
prevalence of AGR and undetected diabetes (II) suggests the need to strengthen 
secondary care. To increase awareness while ignoring secondary care would be a 
recipe for future challenges as the demand for diabetes services increases. „Most-at-
risk approaches‟ have been increasingly used in HIV prevention in Africa. 
Innovations that integrate both approaches to increase efficiency should be explored. 
For example, the substantial numbers of most-at-risk persons and people with 
diabetes could be turned into a resource, by training them to conduct awareness 
promotion and risk factor assessment at the community level as they undergo therapy. 
 
The correlates of AGR can guide risk stratification in resource poor settings 
Availability of accessible and affordable diagnostics is vital for the health system 
(Mostafa et al. 2010). Because blood sugar tests are likely to be unaffordable (II), 
correlates of abnormal glucose regulation can aid in identification of most-at-risk 
persons for type 2 diabetes who can then under-go further evaluation. Lyon et al 
argued that in the absence of tools to diagnose early
 
diabetes, health workers could 
identify proximate risk factors and empirically counsel people on lifestyles (Lyon et 
al. 2004). Risk scores have been demonstrated to be reliable in predicting disease 
(Lindstrom and Tuomilehto 2003). However, such „risk engines‟ have not been 
evaluated in sub-Saharan Africa, where some risk factors like smoking and obesity 
are much less prevalent than in HICs. Studies show that the discriminatory ability of 
risk scores depends on the context for which they were designed (Buijsse et al. 2011). 
 
Study II identifies three correlates of AGR that could be a starting point in risk 
assessment: Obesity, insufficient physical activity, and non-diverse diets. 11% of 
overweight people and 21% of obese people have type 2 diabetes (II). Overweight 
people from rural areas were also significantly more likely to have hypertension (I). 
The significance of obesity in predicting AGR is further supported by the findings 
from ROC analysis (III) which showed that BMI had relatively good correlation with 
FPG. These correlates could plug an important gap as an aid to risk stratification in 
the absence of affordable laboratory tests, so that scarce resources are targeted to the 
most-at-risk groups.  
 
Study I and II also demonstrate the importance of the age threshold of 40 years as a 
marker for heightened risk for type 2 diabetes and hypertension. Type 2 diabetes 
prevalence averages 7% between 40-49 years and peaks at 50-54 years (12%). In the 
age-group studied, inflection in the prevalence curve is noted in the 40-45 year age-
band. According to Nambuya and colleagues, the mean age of new diabetes patients 
seen at Uganda‟s national referral hospital was 45 years while the majority of new 
cases were aged 40-49 – this is a relatively young age compared to an average age of 
65 years at onset of type 2 diabetes in HICs (Nambuya et al. 1996). These findings, 
coupled with the increased likelihood of hypertension from 45 years and above 
suggest a need for closer evaluation of people aged 40 years and over for risk factors. 
 
Based on these observations, it is reasonable to recommend a two-stage risk 
evaluation approach in primary care settings of low income countries such as Uganda 
as follows: 1) All people aged 40 years and above should be assessed for overweight 
and physical activity levels and; 2) based on the first stage of the evaluation, all 
people aged 40 years and above found to be overweight or to have low physical 
activity levels should undergo further evaluation for abnormal glucose regulation and 
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high blood pressure at opportunities when they visit primary care health facilities with 
the capacity to conduct these assessments. Applying the age and bodyweight 
threshold as opposed to mass opportunistic screening for all adults would reduce the 
burden on health facilities by focusing on the most-at-risk people. Targeting the most-
at-risk people has also been shown in some studies to be more cost-effective than 
targeting all people with risk factors (Waugh et al. 2007). 
 
Rapid tests have diagnostic value for type 2 diabetes and utility for screening 
Using WHO and ADA criteria, the percentage agreement between FPG and HbA1C 
rapid tests in classifying diabetes and AGR status is low (III). Similar results were 
found in Europe (Schottker et al. 2011) and India (Muktabhant et al. 2012) with non-
rapid tests. However, study III finds that agreement between FPG and HbA1C in 
classifying diabetes status is much higher among people with risk factors for type 2 
diabetes than the general population. In addition, agreement among the „negatives‟ (i.e. 
those who either test classifies as not having diabetes or AGR) is high independent of 
whether they have a risk factor, suggesting that the two tests have good specificity (III). 
These findings show that rapid tests have utility in evaluation of higher risk persons at 
primary care levels in rural low-income settings. In addition, rapid tests may have value 
in the diagnosis of type 2 diabetes among people with risk factors (obese, overweight or 
hypertensive and people with combinations of these). FPG was found to be much more 
practical in this setting compared to HbA1C (Study III).  
 
Calibration of risk assessment tools for Africa 
This thesis raises questions on the utility of several tools for assessment of type 2 
diabetes related risk factors in the context of sub-Saharan Africa.  Firstly, the marked 
contrast in the prevalence of pre-diabetes between the WHO and ADA cut-offs for 
FPG has ethical and service delivery implications. While the lower ADA cut-off is 
associated with higher screening efficiency (II) (ADA 2013), using it would result in 
a significantly larger number of high risk people needing long term care (II, III), with 
consequences on their quality of life, yet the health system is unlikely to 
accommodate and support all of them. This concern has been raised by the WHO in 
the guidelines for classification of hyperglycaemia (WHO and IDF 2006).  However, 
this thesis shows that by identifying more most-at-risk persons, the lower ADA cut-
off is associated with lower direct medical costs per most-at-risk person detected (II). 
 
Due to the very wide disparity in prevalence of abdominal obesity between men and 
women (I), the WHO cut-offs for classifying waist circumference may not be 
appropriate for African women, a concern that has been raised in other studies 
(Deurenberg 2001, Crowther and Norris 2012). Evidence on the utility of BMI is still 
equivocal with some authorities arguing that waist circumference is a more reliable 
marker (Flegal et al. 2013). In study II, 14% of study participants (i.e. 1 in 7) with a 
normal BMI had AGR, illustrating that BMI is not sufficient to predict the risk of 
type 2 diabetes. Properly calibrated, waist circumference may be easier to measure by 
PHC level health workers than BMI which requires multiple measurements and 
computation.  
 
Because the majority of the study population by definition meets the recommended 
physical activity threshold, the finding that mechanics had a significantly lower 
likelihood of AGR than subsistence farmers raises a query on the actual work 
intensity of subsistence farmers aged 35-60 years in Africa.  These findings could 
imply that subsistence farmers in this age-group are more sedentary than mechanics, 
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and that self-reported physical activity may be insufficient to evaluate the physical 
activity levels of subsistence farmers aged 35-60 years in rural low income settings.  
 
The marked disparity in prevalence of AGR as measured by FPG compared to HbA1C 
(III) supports earlier studies mainly from the United States showing that people of 
African descent have significantly higher glucose independent glycosylation of 
haemoglobin than people of Caucasian origin (Ziemer et al. 2010, Selvin et al. 2011). 
Evidence is also increasingly available that high rates of iron deficiency anaemia 
could raise HbA1C levels due to yet unconfirmed haematological factors (Hardikar et 
al. 2012). However, it is also known that FPG has a lower sensitivity than HbA1C 
(Kumar et al. 2010). FPG levels could also have been generally lowered by the 
occupational habits of this study population who tend to commence farming work 
early in the morning. The implication of these findings is that there is need to re-
calibrate both the FPG and HbA1C rapid tests for Africa. 
 
6.4 COMMUNITY PERCEPTIONS ABOUT PREVENTIVE LIFESTYLES 
Incongruence in community perceptions about type 2 diabetes prevention 
While there is a widespread perception that type 2 diabetes is a very severe disease, 
the same was not reflected in perceptions about preventive lifestyles (IV). Here is a 
community where people with diabetes view obesity as „sickness‟ but the majority 
without diabetes view obesity as „a sign of success‟. High risk foods are linked to 
„enjoyment of life‟. Weight loss is stigmatized, a finding highlighted in other studies 
from Africa (Duda et al. 2006, Rutebemberwa et al. 2013), while some people think 
that „weight gain cannot be controlled‟.  To convince an obese person who feels like 
she/he is „having the best of life‟ to change his/her lifestyle is an enormous challenge, 
especially in clarifying what constitutes health. In two studies from other settings, 
obesity was perceived as less risky than smoking (Silagy et al. 1993, Khattab et al. 
1999). Others have shown that individuals who are aware about their own risk factors 
tend to externalize them as not attributed to their own lifestyle (Lucas et al. 2013). 
 
A possible opportunity for health educators in this context is that communities are 
widely aware of the chronic incurable nature of type 2 diabetes and are concerned 
about the endless injections and the loss of income due to treatment and cessation of 
work (IV). Women are very concerned about the pain of diabetes while men are 
notably concerned about its effects on sexual performance (IV), but all are concerned 
anyway. These concerns are however not translated into a sense of urgency to change 
lifestyles as communities emphasize that change should be slow. These findings raise 
questions about the community‟s „notion of health‟, which appears to be nuanced on 
current wellness than future health.  In at least two other studies, African participants 
have reported a positive outlook on life that discouraged thought about future 
sickness (Stern et al. 2010, Cooper et al. 2012). The findings support the need for 
health information that targets to change the community‟s notion of health. Health 
information should empower communities to change their perceptions about obesity 
and high risk diets and to link healthy choices now to future health gains. 
 
Barriers to lifestyle change 
Study participants said they were willing to change their diet, physical activity levels, 
and monitor their health but change was inhibited by several barriers (IV). Regarding 
diet, participants said their ability to change is limited by poverty, access to some 
foods, cost of the food and the large sizes of their families. They said that sugar and 
cooking oil were difficult to exclude from their diets because of their good taste (IV). 
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In the rural areas, „bad sugars‟ are wrongly associated with sweet potatoes (a staple 
food) because of their sweet taste. „Refined foods‟ like polished rice or maize flour 
are not cited as unhealthy, despite their increase in rural Africa (Muhihi et al. 2013).  
 
Participants said to too that while they are able to adjust their physical activity levels, 
they could only do so using familiar forms of activities. Physical activity was viewed 
as „informal day-to-day activities‟ rather than organized exercises. Domestic chores 
were the preferred platform for increasing their physical activity. The range of chores 
they suggest are in contrast with preferences among urban residents in Cameroon, 
who viewed informal physical activities negatively (Kiawi et al. 2006), a discrepancy 
attributed to the rural-urban difference in context. In two studies in North America, 
participants too preferred gym work and organized exercise (Miller and Marolen 
2012, Bishop et al. 2013) to informal activities, a difference attributed to differences 
in norms. In the Iganga-Mayuge context, non-familiar activities like running (or 
jogging) are viewed as „strange‟, „laughable‟ or „not suitable for adults‟ (IV).   
 
These findings clarify some dimensions in behaviour change education messages 
needed to promote lifestyle change. For behaviour change education to be effective 
individuals, households and communities need to be offered lifestyle choices that are 
relevant to their context and within their means. In the context of rural Uganda, 
messages should emphasize familiar forms of physical activity, with domestic work 
as the launch platform for increased physical activity. Health educators ought to 
discuss with individuals, households and communities to identify more accessible 
alternatives to the expensive high protein foods and other food groups they are not 
able to access easily.  
 
Study participants feel that it is possible to monitor their health but they had concerns 
(IV). Regarding seeking health check-ups in health facilities, three of their greatest 
concerns were the responsiveness of health workers if someone has no ailment,  not 
knowing what the „check-up‟ entails, and the fear of unravelling „what is not known‟. 
These findings resonate with low confidence in health services and other known 
barriers to access to health services in low income settings (Brenner 2002, 
Rutebemberwa et al. 2009). With the many competing priorities and shortage of 
health workers in Uganda‟s health system, establishment of wellness clinics or 
outreaches by health workers is likely impractical as it would over-burden an already 
over-stretched workforce. However, creative ways of empowering individuals to self-
assess (e.g. their weight and BMI) may be necessary. Because some of these 
procedures are relatively simple, assessment procedures like self-weighing can be 
undertaken by individuals, community health workers and expert clients in their 
communities or at health facilities, without additional burden to health services. 
 
Behaviour change education 
This assessment shows that behaviour change education is required as a key strategy 
for NCD prevention in low income settings (I, II, IV). Paradoxically, people who 
were more knowledgeable about lifestyle diseases were also more likely to be 
overweight (I). Although this may be linked to their higher socio-economic status, it 
also demonstrates that awareness-creation per-se may not translate into lifestyle 
change.  Therefore, health education should not only create a critical mass of the 
population that is aware of life-style diseases but it should promote change in 
lifestyles, both at the individual and the community level. Study IV shows that people 
afflicted or at higher risk for type 2 diabetes believe that change ought to be slow and 
requires a major readjustment in what they are used to. Some behaviour change 
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theories seem to support this notion of phased interventions (Glanz et al. 2008). 
However, recent meta-analyses do not show convincing evidence of an added benefit 
from phased interventions (Tuah et al. 2011, Mastellos et al. 2014). Study IV shows 
that individuals are willing to change behaviour, but they are encumbered by several 
barriers. To change behaviour therefore, health education ought to go beyond the 
message to show the individual that change is possible within their means.  
 
An African-centred behaviour change education framework is necessary (BeLue et al. 
2009). Based on the findings from this study, health education messages suitable for 
this context would consist of: 1) Messages about the high burden of type 2 diabetes 
and abnormal blood sugar levels among people older than 35 years and its 
implications if no actions are taken (II), 2) messages about the substantial prevalence 
of risk factors in some population groups (I), linking lifestyle factors to disease and 
dispelling the normative association of risky lifestyles with success (IV), 3) messages 
that debunk current misconceptions about health and wellness and link current 
lifestyles to future health, future quality of life, and lower health care costs (IV), 4) 
Options regarding physical activity increments that communities are familiar with 
(e.g. increasing the intensity and duration of domestic work, walking or cycling) or 
non-familiar activities that they might consider (IV), 5) Overcoming barriers to diet 
by considering alternatives that are accessible and justifying urgency for change (IV), 
6) Addressing gender, rural/urban and socio-economic disparities in risk factors and 
beliefs about obesity (I, IV), and 7) How individuals can self-monitor some important 
lifestyle parameters like weight, diet and physical activity and the importance of 
wellness checks (III,IV). At the individual level, this could involve „self-persuasion 
approaches‟ where individuals are guided to develop their own convictions for 
changing behaviour (Baldwin et al. 2013). At the community level, the importance of 
the normative environment in influencing individual behaviour (Ajzen 2011) should 
be attended to. Modern health education theory supports ecological models that strike 
a balance between individual behaviours and systems or societal influences (Brenner 
2002), as well as „culturally sensitive‟ health education that uses „community own‟ 
resources and addresses barriers to change (Netto et al. 2010).  
 
6.5 A NEED FOR ‘SMARTER’ HEALTH SYSTEMS 
The ethics of action and inaction 
Study I and II indicate that at least one quarter of the population of people aged 35-60 
years are either overweight, have hypertension or have pre-diabetes. A systematic 
search for all these people and those with un-detected disease is impractical given the 
current capacity of the health system to provide them with the necessary continuum 
of quality care to avert progression to disease. Failure to provide services would raise 
major ethical challenges. For example, the screening activities performed for 1,497 
people in study II led to a doubling of clients seeking care at Iganga‟s only public 
diabetes treatment clinic. This was because all participants suspected to have diabetes 
or pre-diabetes based on the screening test were referred to this clinic for further 
investigation (II). Because this was not part of the clinic‟s routine, special 
arrangements had to be made to handle the upsurge in clients. The clinic required 
more drugs and sundries than their usual need. Negotiations were held with the 
hospital team and remedial measures were undertaken to provide additional logistics 
like glucometers, sphygmomanometers, lancets and blood glucose test strips for 
confirmatory screening. These remedies were possible because the funding for these 
studies was earmarked. To undertake similar activities in the general health system 
would result in major logistical constraints, with important ethical implications.  
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Ethical challenges are also expected to arise from the level of intensity of lifestyle 
measures prescribed for people with risk factors for type 2 diabetes. Although studies 
show that pragmatic interventions are much less efficacious than intensive 
interventions (Simmons et al. 2010), there are recent concerns that in an attempt to 
achieve rigorous therapeutic targets, people with risk factors are increasingly treated 
as if they have the disease (Kreiner and Hunt 2013). „Turning healthy people into 
chronic patients‟ substantially reduces their quality of life (Kreiner and Hunt 2013). 
 
On the other hand, low income countries can no longer afford to ignore NCDs on the 
basis of insufficient resources. The fact that prevalence of risk factors is substantial, 
the potential for substantial increase in disease burden, and the widespread lack of 
awareness about lifestyle diseases and their risk factors show that something needs to 
be done. With awareness creation and behaviour change communication as an option 
(I), total inaction on the basis of lack of resources is not ethically justifiable.  
 
Restructuring the health system to integrate NCD services 
These four studies raise possible options for restructuring the health systems to 
increase its responsiveness to the rising challenge of NCDs in contexts similar to this. 
As far as possible, assessment for three key risk factors: overweight, insufficient 
physical activity, and non-diverse diet needs to be integrated into out-patient services 
for PHC level facilities, especially targeting people aged 40 years and above. This can 
be introduced to the lowest level primary care facilities including HC II. People with 
risk factors should receive health education at the time of assessment. Traditional 
health education sessions in health facilities should be modified from their current 
focus on infectious and acute conditions to include wellness and lifestyles, and should 
also be open to people who are well but with risk factors. Overweight people older 
than 40 years should be offered further evaluation for abnormal glucose regulation 
and hypertension. This can be provided at the HC III and above because they have 
laboratories and clinical staff. People found to have AGR and hypertension would 
represent the most-at-risk persons and would need behaviour change education. 
Mechanisms to enhance their adherence to lifestyle change and therapy would need to 
be put in place including follow-up clinics, community led peer support groups, and 
the use of expert clients. Along-side these measures should be the implementation of 
widespread awareness creation on NCDs at the national and sub-national levels, 
involving stakeholders. 
 
Smarter health systems would be necessary 
Suggested actions from this thesis all have implications to the health system, in light 
of scarce resources. Implementation of individual and community based programs 
requires a „re-tooling‟ of primary and secondary care in several health system 
building blocks. Awareness creation at the community level would require 
development of context specific messages and disseminating them (Health 
information) (I). Service packages that include measures for individual level and 
community level prevention and treatment ought to be developed (Service delivery).  
Also highlighted is the importance of selective evaluation of people with 
combinations of risk factors to identify most-at-risk persons. Algorithms and 
guidelines for risk evaluation and diagnosis would need to be developed 
(Diagnostics), while the appropriate lifestyle counselling algorithms for most-at-risk 
persons and medicines for treatment of confirmed people with disease need to be 
made available (Medicines and therapeutics). Health workers would have to be re-
oriented to be able to offer these services (Human resources), while mechanisms for 
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funding these additional programs would have to be elucidated (Financing). All these 
actions would require investment of resources at different levels.  
 
The severe shortages of health workers faced by sub-Saharan Africa raise the 
question of who should provide these services. Major constraints already exist in the 
efficiency of current primary care (Maher et al. 2010, Mbanya et al. 2010). Many 
effective interventions for CVD prevention and management are not even affordable 
or well implemented in high income countries and would be a far cry for the poorest 
countries (Joshi et al. 2008). However, there is a window of opportunity to prevent 
the burden of NCDs from reaching its full magnitude as seen in some transitioning 
countries in Asia (Joshi et al. 2008) by applying measures when the epidemic is in its 
infancy. This requires the rapid deployment of strategies to curb increase in risk 
factors. Such strategies need to be tailored for LICs for them to be affordable, 
effective, and accessible to communities, higher risk groups and people with disease.  
 
Given the many challenges our health systems face, innovations are needed to 
overcome the obvious challenges regarding financing, human resources, organisation 
of services, quality, availability of medicines and therapeutics and approaches to 
health promotion, by elucidation of a viable chronic care model for LICs. These 
challenges are not new and have been observed in services for acute conditions 
(Rutebemberwa et al. 2009, Nanyonjo et al. 2012). Integration of additional 
preventive measures like community education, counselling for people with risk 
factors and treating the likely increase in number of patients could have a disruptive 
effect on the already inefficient services. Innovative ways of mobilising community 
resources to contribute to service provision are needed to offset the increased pressure 
on formal services. Greater involvement of communities by transferring to them some 
responsibilities for health education, risk assessment and follow-up of higher risk 
persons could be explored. In addition, because some risk assessment procedures like 
assessing obesity, physical activity and diet are simple, service delivery models that 
empower the high risk individual, expert clients and community health workers to 
assess them and provide lifestyle counselling could be explored to offset the 
additional workload to formal health workers.  
 
There is also the potential to learn from HIV treatment programs, a chronic infectious 
disease for which the health systems of LICs adapted rapidly and in many ways 
successfully (Whyte 2012), especially regarding detection, initiation of care, follow-
up and adherence support (Chalker et al. 2013). HIV programs show that 
multipronged support systems that employ adherence targets, follow-up 
appointments, and involvement of community health workers can increase adherence 
(Agnarson et al. 2010). However, it should be noted that the funding streams for HIV 
programs have been robust, often involving the mobilisation of resources and the 
implementation of a progressive agenda at the global and national level. There has 
also been significant political commitment to these programs by governments in SSA. 
 
Samb and colleagues note that chronic disease interventions could contribute to 
strengthening the capacity of health systems to deliver a comprehensive range of 
services and should be a litmus test for health-systems strengthening in LICs (Samb 
et al. 2010). However, integration of even the basic interventions among those 
suggested would require substantial re-orientation of the current service delivery 
paradigm at different levels of the health system (Samb et al. 2010). I have labelled 
these improved models with the adage „smart health systems‟ that can accommodate 
the concerns of both acute and chronic conditions and „frugal health systems‟ that 
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leverage the potential of existing resources (communities, high risk persons and 
people with disease) to take charge of the bulk of the NCD agenda.  
 
6.6 METHODOLOGICAL CONSIDERATIONS 
Context 
All studies (I-IV) were conducted in a HDSS setting, where populations know that 
they are under observation. However, there were no on-going interventions on NCDs 
at the population and health facility level in the HDSS which could interfere with the 
results of these studies. 
 
Measurement of socio-behavioural variables 
Methodological challenges were noted in the tools used to measure socio-behavioural 
variables. The nature of the questions used could have resulted in misclassification 
biases for key behavioural characteristics like socio-economic status, smoking, 
dietary diversity, knowledge about lifestyle diseases, physical activity, and stress. 
Using principal components analysis to assess socio-economic status means that the 
SES classifications may not be comparable with other populations as the assets 
common in this population may not be the same elsewhere. The tool used to assess 
knowledge about lifestyle diseases did not apply weights to the different items but 
assumed a uniform score per item, yet all items may not signify the same level of 
knowledge. This could have resulted in over-estimating the level of knowledge. 
Assessment of physical activity using self-reports could have resulted in over-
estimation of physical activity levels. The stress score used in study I was adapted 
from one used in Sweden and has not been validated in sub-Saharan Africa. It may 
not have sufficient specificity to stressful situations in sub-Saharan Africa. Using 
self-reports to assess smoking and alcohol consumption status could have resulted in 
reporting bias, hence under-counting cases (I, II). In addition, dietary assessment was 
limited to dietary diversity scores that do not take into account the quantity of 
nutrients eaten and are liable to recall bias.  
 
These limitations were anticipated and mitigated during study design by as much as 
possible using validated tools. Principal components analysis is a standard approach 
that has been used in demographic surveillance in many countries in Africa. The 
knowledge score used in this analysis was subjected to a reliability analysis and found 
to have high internal consistency (Cronbach‟s Alpha=82%). The assessment of 
physical activity, alcohol taking and smoking were standardised by using validated 
items that have been employed in other risk factor surveys including in Africa. The 
items in the stress scale (e.g. anxiety and lack of sleep) are all relevant to the local 
setting. Diet quality has also been shown in recent studies to have a strong link to 
cardio-vascular health (Atkins et al. 2014). A full assessment of nutritional food 
values was outside the scope of this thesis. Hopefully, these considerations mitigated 
the potential biases in the measurements.  
 
Measurement of physical characteristics 
Limitations are noted from using of BMI to assess overweight and obesity and as the 
dependent variable in testing for associations despite its known shortfalls (I, II, III). 
BMI is known to be affected by muscle mass and in muscular subjects, is not a good 
measure of adiposity (Gupta and Kapoor 2014). However, BMI categories have been 
calibrated and recommended by the WHO as a measure of CVD risk, and are widely 
used in NCD risk assessments, including the STEPs (WHO 1995).  Moreover waist 
circumference, which could be the alternative dependent variable (I) showed a very 
 52 
 
high disparity between sexes and would likely bias the analysis if used instead of 
BMI. All categorisations (blood pressure, physical activity and BMI) were based on 
the standard criteria recommended by the WHO.  
 
Blood sugar tests 
Study II and III determined AGR on the basis of single rapid FPG and HbA1C tests. 
Single tests are associated with lower specificity, and a definitive diagnosis of 
diabetes is based on multiple tests. However, the use of a single test in this study was 
to evaluate their utility for screening and not for diagnosis. Study II used the FPG test 
to assess AGR. FPG is recommended by the WHO as the first line screening test for 
AGR (WHO and IDF 2006). However, it could have led to undercounting of AGR 
cases as glucose intolerant people with a normal FPG were probably missed. This 
could have led to a misclassification bias, resulting in some people with AGR being 
classified as not having it. The effect of this would be to reduce the observed strength 
of association between the factors assessed and AGR. However, the proportion of 
glucose intolerant people with a normal FPG is likely to be very low (Hu et al. 2010). 
Multiple simultaneous tests too are of limited value in screening as their cost would 
be prohibitive.  
 
The use of rapid tests rather than laboratory based tests could also contribute to 
misclassification biases. However, misclassifications could affect the results in either 
way. Current evidence shows that some modern point-of-care tests have comparable 
accuracy to laboratory based tests including those used in these studies (Little 2005, 
Lenters-Westra and Slingerland 2010, Wood et al. 2012). In addition the use of rapid 
tests was purposive because laboratory based tests are more costly for the health 
system and less accessible to primary care facilities compared to rapid tests.   
 
The Oral Glucose Tolerance Test (OGTT) (which is often used as the gold-standard 
for diagnosis of type 2 diabetes) was not performed, hence the lack of data on 
sensitivity and specificity of the tests, and the exclusion of „Impaired Glucose 
Tolerance (IGT)‟ in our comparisons. However, the OGTT would be a cumbersome 
test to apply to this number of respondents, and has limited value in screening (Anand 
et al. 2003). There is currently no „perfect‟ screening test for early detection of pre-
diabetes (Waugh et al. 2007), and all available tests, including the OGTT are to a 
degree presumptive. In addition there is a lot to learn from a match-up of two tests 
(FPG and HbA1C). Their level of convergence would provide an insight into the 
implications of their application in a PHC setting. This assessment focused on tests 
that can be used on a massive scale at PHC levels so as to demonstrate the challenges 
in their use, as opposed to the more rigorous tests like the OGTT, which may not be 
applicable as primary care screening tools. Moreover, there have been numerous 
studies on the sensitivity and specificity of FPG and HbA1C compared to the OGTT 
and exploring this further might not generate new information. 
 
Another methodological challenge is that HbA1C is known to be affected by 
haemolysis, haemoglobinopathies, triglycerides, and drugs commonly used in Africa 
like Aspirin (Kumar et al. 2010, Unnikrishnan and Mohan 2013). This could have 
explained the high levels of AGR observed with HbA1C compared to FPG. However, 
most of these confounders tend to lower, rather than increase HbA1C values, except 
for iron deficiency anaemia which has been recently linked to high HbA1C values. 
Iron deficiency anaemia is relatively common in rural communities in sub-Saharan 
Africa, as a result of nutritional factors, gastro-intestinal bleeding, and hookworm 
infestation. 
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Cost analysis 
Limiting the cost analysis to direct medical costs of a single service (screening) (II) 
leaves out many other indirect costs, let alone the cost of long term treatment of most-
at-risk persons and people with disease that are identified. Study II however only 
provides preliminary information. Further studies are needed to estimate the longer 
term benefits of screening with regard to deaths averted and DALYs gained. 
 
Representativeness and generalizability 
Overrall, generalizability of the findings of this thesis (all studies) applies to the age-
group 35-60 years in a predominantly rural low income setting. This age-group was 
purposively selected as a possible higher risk group for type 2 diabetes and CVD risk 
factors, to provide a more focused evaluation, rather than a general population view. 
 
One of the limitations of the qualitative study (IV) is that participants were not on any 
formal lifestyle programs and were not aware of the recommended behavioural 
options regarding diet and physical activity. This challenge was mitigated by using a 
motivational interviewing approach in which participants were educated about the 
recommended behaviour before asking them to explain whether it was feasible to 
them. Another consequence of this challenge was that there was no discussion of 
motivators for change and intensity of lifestyle adjustments but these issues were 
outside the scope of these studies. Likewise, the categorisation of FGD participants 
on the basis of blood sugar status likely led to misclassification of some participants, 
since the test used for this classification (FPG) is not confirmatory. However, the 
interest in this study was to assess if perceptions were influenced by one‟s being told 
his/her suspected risk status, rather than affirmed status. The generalizability of 
findings in study IV, while not statistical, applies to enriching our understanding by 
„zooming in‟ into context specific perceptions about lifestyle change in settings 
similar to rural Iganga.  
 
Moderators for the qualitative studies 
The limitations of using a lead investigator from a biomedical background are 
acknowledged. However, the lead investigator had sufficient experience in FGDs, and 
was supported by an interdisciplinary team. Both the moderator and assistant-
moderator were males, with the potential bias that women may not have opened up 
about their some of their concerns especially regarding sex. This was partly mitigated 
by using a female interpreter and female notes-taker, and sexuality was not a key 
research question for this study.  
 
Statistical rigour 
Study I employed a logistic regression model. However, because of the relatively 
frequent prevalence of the key variables assessed, prevalence rate ratios (PRR) would 
have been more accurate than odds ratios (OR), and a Poisson regression model 
would have been more accurate. Indeed this approach was used in the regression 
analysis for study II. Using the Logistic model instead of the Poisson model could 
have resulted in amplified estimates of the measures of association. Another 
limitation of this risk based approach is that based on the regression models in study I 
and II the four factors explained less than 40% of the variability observed. 
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7 CONCLUSIONS AND RECOMMENDATIONS 
 
1. The prevalence of overweight and hypertension in people aged 35-60 years in this 
setting is substantial amidst low awareness about lifestyle diseases, hence the 
need for mass awareness creation about lifestyle-related risk factors (I).  
 
2. There is a high prevalence of abnormal glucose regulation among people aged 35-
60 years in this predominantly rural setting, further underpinning the urgency for 
behaviour change education and strengthening of secondary care (II).  
 
3. Obesity, insufficient physical activity and unhealthy diets were significantly 
associated with abnormal glucose regulation and could aid in risk stratification at 
primary care levels (II). 
 
4. Although low in the general sample, agreement between HbA1C and FPG rapid 
tests is high among people with risk factors for type 2 diabetes and in negative 
results, with implications for primary care based risk assessment (III).  
 
5. Current cut-offs for available risk assessment measurements (especially waist 
circumference,  HbA1C levels, and FPG cut-offs for pre-diabetes) may not be 
appropriate for sub-Saharan Africa (I,II, III) 
 
6. Although people at higher risk of type 2 diabetes perceive type 2 diabetes to be a 
very severe disease, their sense of urgency for uptake of preventive behaviours is 
low (IV) 
 
7. People aged 35-60 years said that while lifestyle change was practicable, several 
barriers stood in their way regarding diet, physical activity and self-monitoring; 
these barriers need to be overcome at individual and household level (IV).  
 
8. Suggestions for strengthening the primary care level response to type 2 diabetes 
include: mass awareness creation, behaviour change communication on lifestyles, 
identifying the most-at-risk persons and supporting them to change behaviour, 
and strengthening capacity for diagnosis and treatment of people with type 2 
diabetes (All) 
 
Based on these conclusions, the following recommendations arise: 
 
Mass community health education on type 2 diabetes and NCD risk factors and 
lifestyles is necessary to avert escalation of risk (I).  
 
Due to the high prevalence of pre-diabetes and hypertension, mass opportunistic 
screening would be impractical, given the health system constraints of handling an 
up-surge of high risk persons (II). Overweight, insufficient physical activity and 
unhealthy diets could be used to identify the most-at-risk persons for type 2 diabetes 
at primary care levels (II). These should then be selectively evaluated for abnormal 
glucose regulation and hypertension, given that mass screening is likely not 
affordable (II). This two-level approach to risk assessment, especially for people aged 
40 years and above, is necessary, so that scarce resources are targeted to the most-at-
risk persons. 
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Rapid tests may have diagnostic value for type 2 diabetes among people with risk 
factors and in screening to identify most-at-risk persons to type 2 diabetes (III). There 
is however a need for re-calibration of some risk assessment tools to provide more 
suitable reference ranges for Africa, especially waist-circumference, HbA1C, and the 
FPG cut-offs for pre-diabetes (I,II, III).  
 
There is need for health information targeting to change the communities‟ notion of 
health and wellness. Specifically, messages should change the perceptions that 
obesity, tasty high risk foods, and sedentariness represent a „good life‟ (IV). Health 
educators should plan with clients on how to overcome barriers to lifestyle change 
especially in ways familiar to these predominantly rural communities (IV).  
 
Given the gross challenges our health system faces, integration of measures like 
community education, selective risk evaluation, counselling of high risk people and 
improved treatment of people with type 2 diabetes require a re-organisation of 
existing primary care service packages and their delivery mode. Innovative „smart 
health systems‟ that shift some of these responsibilities to affected individuals and 
communities are needed (All). 
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8 POLICY IMPLICATIONS 
 
Low income countries like Uganda have an opportunity to address some risk factors 
for type 2 diabetes when their prevalence is still low (e.g. smoking and obesity), in 
addition to risk factors that are more frequent (e.g. overweight, hypertension and non-
diverse diets). Because prevalence of most-at-risk states (pre-diabetes and pre-
hypertension) among people aged 35-60 is substantial, it may not be feasible to 
massively assess these risk factors at the population level because of the potential 
burden to the health system. Currently, population level programs to create mass 
awareness about risk and disease appear more feasible. These activities should be 
integrated into existing services both at the health facilities and in communities but 
require a rethinking and re-tooling of the „integrated prevention package‟ to include 
lifestyle change. Likewise, to reduce the workload on health workers, innovative 
ways of using the „resources‟ in communities should be harnessed, as has been done 
for programs like maternal and new-born health and HIV care. Simple tasks like 
measuring waist circumference and BMI, as well as counselling of people with risk 
factors could be shifted to community resource persons and „expert clients‟. Health 
education paradigms should also change, to balance current and future health 
concerns, and to change the communities‟ notion about health and wellness.  
 
The health system implication of the concentration of type 2 diabetes and its risk 
factors in some population groups is that where population level prevalence is low 
(typical of low income countries), interventions should incorporate risk stratification, 
so that the more resource intense activities like lifestyle counselling are targeted to 
higher risk categories. Since interventions targeting high risk persons have been 
shown in many studies to be more efficacious in averting progression to disease, the 
ideal situation would be to periodically screen for pre-diabetes and hypertension 
among all people aged 35-60 years (mass opportunistic screening). However, given 
the many challenges that our health system is grappling with, such a program may not 
be affordable. Rather, selective evaluation of people aged 40-60 that already have 
some risk factors may be considered, so that scarce resources are targeted to the most-
at-risk persons. The preferred PHC level screening test would be FPG, due to its 
practicality. 
 
Because of the high burden of abnormal glucose regulation, it is imperative that the 
health systems of low income countries undertake steps to improve secondary care. 
This should include strengthening diagnosis, treatment and follow-up care. Therefore, 
in addition to the population level activities, secondary care will have to be 
strengthened. Service delivery approaches would also have to be re-oriented towards 
more autonomy for the person with diabetes and the most-at-risk person in taking 
charge of their health (focus on the patient and the most-at-risk person).  
 
The need to re-calibrate and standardize risk assessment tools for sub-Saharan Africa 
does not require over-emphasis, especially regarding FPG, HbA1c, BMI and waist 
circumference. PHC level health workers also need guidelines and job-aids for 
assessment of socio-behavioural factors including alcohol consumption, smoking, 
physical activity and diet.  
 
In a health system with minimal PHC level NCD services, challenges on how to 
handle high risk persons identified through risk assessment need to be addressed. 
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Effective counselling for such people should include discourse on how to overcome 
individual and household barriers to lifestyle change. Health educators should also 
present lifestyle adjustments that are within the options that people are familiar with. 
Context specific counselling packages that lay out the different barriers and options 
(both familiar and un-familiar) with regard to diet, physical activity and self-
monitoring of health should be developed. 
 
A key question that needs to be answered is: „should we tamper with NCDs given that 
a possible increase in demand for NCD services will spiral back into the health 
system?‟ Yet we are faced with the reality that we can no longer say that there are no 
cost effective interventions for prevention and mitigation of NCDs. „The ethics of 
inaction‟ seems to tell us that we need to act now, before NCDs overwhelm the health 
system. Lastly, a general community approach is inevitable for most countries to 
create critical awareness about lifestyles and to in-build lifestyle change from the 
young age, as much as possible using community resources. This requires a critical 
mass of the population that is aware and sensitised about what to do to improve 
lifestyles. Community health workers, most-at-risk persons and people with disease 
are a vast resource that can be used in delivery of prevention and care services for 
type 2 diabetes. 
 
 
EPILOGUE 
The thesis facilitates a link between diabetology and health systems, illuminating 
some important issues on health information, service delivery options, and 
formulation of therapeutic packages for lifestyle education. The suggestions here-in 
contribute to only part of the health system building blocks. These findings highlight 
possible options for integration of NCD prevention into the health system of a typical 
low income country. However the challenges of adding NCD packages to 
overstretched health systems come to light. 
 
Reflecting on the future: As more evidence emerges on the epidemiology and health 
system actions to address NCDs and type 2 diabetes in LICs, there is a need to design 
NCDs service packages based on simple cost-effective interventions. Information 
generated from these studies shall be used to develop service packages for targeting 
prevention and treatment of type 2 diabetes. These shall be tested using different 
service delivery models to determine suitable approaches to roll out the integration of 
type 2 diabetes and NCD prevention and care in resource constrained settings. 
Packages should include both individual level and community level interventions. 
Cost-effectiveness components shall be included to gauge the economic benefits and 
effectiveness of such service packages.  
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